Get notified of page updates

Search Results: (30 results)

New Search

PRINTER FRIENDLY PAGE 301 through 330 of 344

Phase 1/1b Study of Oral Drug PMD-026 in People with Metastatic Breast Cancer and Metastatic Triple Negative Breast Cancer

PMD-026 is a study for people who have been diagnosed with metastatic triple negative breast cancer (mTNBC) who have no further treatment options. This research study is investigating if a study drug called PMD-026 is safe and effective for patients with mTNBC. NOTE: This study is no longer enrolling.

Clinicaltrials.gov identifier: NCT04115306

Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to the Usual Radiation Treatment for Newly Diagnosed Early Stage High Intermediate Risk Endometrial Cancer

The purpose of this study is to determine whether the addition of the immunotherapy agent pembrolizumab to radiation therapy is more effective than radiation therapy alone in reducing the risk of cancer recurrence in patients with newly diagnosed stage I-II endometrial cancer that is MSI-High. This study is no longer enrolling.

Clinicaltrials.gov identifier: NCT04214067

A Study of EDP1503 in Patients With Colorectal or Triple Negative Breast Cancer or Cancer That Came Back After Treatment with a Checkpoint Inhibitor

Medicines that affect bacteria in the stomach and intestines may assist immunotherapy agents like pembrolizumab (Keytruda) in treating cancer. This study will look at the effect of a drug, EDP1503 on enhancing the anti-cancer response when used with pembrolizumab, in patients with advanced metastatic colorectal carcinoma, triple-negative breast cancer, or cancers that have recurred after a type of immunotherapy known as an immune checkpoint inhibitor. NOTE: This this study is no longer enrolling patients.

Clinicaltrials.gov identifier: NCT03775850

People with stage 1-3 cancer

RESTORE: A virtual study comparing 2 digital apps to improve mental and physical well-being of patients with stage I – 3 cancer

Many cancer patients experience cancer-related distress, which includes psychological symptoms of anxiety and depression. The RESTORE study will enroll up to 415 adults who have been diagnosed with stage I-III cancer. The goal is to test how effective two different apps are at improving physical and mental health. Participants use their smartphone or tablet to download and access their assigned treatment app without ever needing to visit a clinic in person.

Clinicaltrials.gov identifier: NCT05227898

Abiraterone/Prednisone, Olaparib, or Abiraterone/Prednisone + Olaparib in Patients With Metastatic Castration-Resistant Prostate Cancer With DNA Repair Defects

This is a phase II study looking at different treatment combinations for men with metastatic, castration resistant prostate cancer (mCRPC) to see which is most effective for improving progression free survival (keeping the cancer from progressing). The study will include testing for genes within the tumor to determine eligibility for the study.

Patients with tumors that have ATM, BRCA1 and/or BRCA2 mutations or defects will be randomly assigned to one of the treatment arms of the study. Patients with tumors that have mutations in other DNA repair genes including FANCA, PALB2, RAD51, ERCC3, MRE11, NBN, MLH3, CDK12, CHEK2, HDAC2, ATR, PMS2, GEN1, MSH2, MSH6, BRIP1, or FAM175A will be assigned to Arm IV with single agent olaparib. NOTE: This study is now closed.

Clinicaltrials.gov identifier: NCT03012321

University of Hawai'i Cancer Center: 50 Years of Progress

Mobile Mindfulness Meditation Intervention to Improve Neuropathy in Cancer Survivors

Aloha! The University of Hawai‘i Cancer Center is running a mobile app study to see how it impacts cancer-related neuropathy. We are asking people who have been diagnosed with cancer, have finished primary treatment and are experiencing neuropathy if they would like to use a mobile app for mindfulness meditation to see if it helps their neuropathy.

Interested participants will be asked to follow the link for either anxiety OR neuropathy and to participate in only one of the studies, one time only. Upon enrollment, you will randomly be assigned to begin using the mobile app either immediately or after eight weeks. You will be asked to complete online questionnaires about your well-being upon your initial enrollment, 8 weeks later, and 16 weeks later.

Clinicaltrials.gov identifier: NCT03581357

Niraparib + Ipilimumab or Nivolumab in Pancreatic Cancer that Has Not Progressed After Platinum Chemotherapy (Parpvax)

The purpose of this study is to look at the effectiveness, safety, and anti-cancer activity of the drug Niraparib combined with one of two immunotherapy agents: Ipilimumab or Nivolumab on patients with locally advanced or metastatic pancreatic cancer. Patients in this study must also have previously received Platinum-based chemotherapy without evidence of disease progression. NOTE: This study is no longer enrolling patients.

Clinicaltrials.gov identifier: NCT03404960

Parenting Adolescent-Aged Children While Managing a Parental Cancer Diagnosis – Share Your Story

The study explores how families faced with a parental cancer diagnosis communicate, or why they choose not to communicate, with their children about the cancer diagnosis, treatments, and other related topics. At least one family member (diagnosed parent or non-diagnosed parent) is asked to participate, but more than one member can sign up to be interviewed. NOTE: This study is no longer enrolling people.

Mobile Mindfulness Meditation Intervention to Improve the Well-Being of Cancer Survivors

Aloha! The University of Hawai‘i Cancer Center is running a mobile app study to see how it impacts different areas of well-being in cancer survivors – namely, anxiety and cancer-related neuropathy. We are asking people who have been diagnosed with cancer and finished primary treatment if they would like to use a mobile app for mindfulness meditation to see if it impacts anxiety.

Interested participants will be asked to follow the link for anxiety. Upon enrollment, you will randomly be assigned to begin using the mobile app either immediately or after eight weeks. You will be asked to complete online questionnaires about your well-being upon your initial enrollment, 8 weeks later, and 16 weeks later.

Clinicaltrials.gov identifier: NCT03581357

Treatment study for people with advanced colorectal, gastric and gastro-esophageal junction tumors

Nous-209 Genetic Vaccine for the Treatment of Microsatellite -High (MSI-H) Colorectal, Gastric and Gastro-esophageal junction Tumors

The goal of this cancer treatment study is to find the best dose and learn how safe and effective this cancer vaccine is for treating advanced colorectal, gastric and gastro-esophageal junction tumors that test positive for the biomarkers MSI-High or dMMR. Participants will receive the vaccine in combination with the immunotherapy drug Keytruda (pembrolizumab).

Clinicaltrials.gov identifier: NCT04041310

A Study of Rucaparib Verses Physician's Choice of Therapy in Patients With Metastatic Castration-resistant Prostate Cancer and Homologous Recombination Gene Deficiency (TRITON3)

The purpose of Triton3 is to determine how patients with metastatic castration-resistant prostate cancer, and an inherited gene mutation or tumor genetic deficiency, respond to treatment with the PARP inhibitor rucaparib compared to treatment with physician's choice of abiraterone acetate, enzalutamide, or docetaxel. NOTE: This study is no longer enrolling patients.

Clinicaltrials.gov identifier: NCT02975934

Prostate Cancer Genetic Risk, Experience, and Support Study (PROGRESS)

Prostate Cancer Genetic Risk, Experience, and Support Study (PROGRESS) is a national, patient-driven registry for any male who has undergone or is currently undergoing genetic testing for prostate cancer. Note: This study is no longer enrolling.

A Study of Combination Immunotherapies in Patients Who Have Previously Received Treatment with Immune Checkpoint Inhibitors (QUILT-3.055)

Immune checkpoint inhibitors immunotherapy drugs that allow the immune system to find and destroy cancer cells.

This study will use a combination of immunotherapies in people who's cancer got worse after treatment with a PD-1 or PD-L1 immune checkpoint inhibitor. NOTE: This study is no longer recruiting.

Clinicaltrials.gov identifier: NCT03228667

Safety and Efficacy of Olaparib Combined with Agents Targeting DNA Damage Repair Compared to Olaparib Alone

The purpose of this study is to assess the efficacy and safety of treatment with the PARP inhibitor, olaparib combined with the drug Ceralasertib compared with olaparib alone for patients with Triple-Negative Breast Cancer.

NOTE: This study is no longer enrolling patients.

Clinicaltrials.gov identifier: NCT03330847

A Study of Nivolumab Combined With Ipilimumab and Nivolumab Alone in Patients With Advanced or Metastatic Solid Tumors of High Tumor Mutational Burden

This study is researching a combination of two immunotherapy drugs for advanced solid tumors that contain a tumor biomarker known as "High Tumor Mutation Burden" (TMB-H). The researchers are studying whether treatment of these tumors with a combination of the drugs nivolumab plus ipilimumab is safe and effective compared with nivolumab alone. NOTE: This study is no longer enrolling.

Clinicaltrials.gov identifier: NCT03668119

A Study of Nivolumab in Selected Uterine Cancer Patients

The purpose of this study is to test the effectiveness, safety, and tolerability of Nivolumab on patients with metastatic or recurrent uterine cancer.

Nivolumab is a type of immunotherapy known as an immune checkpoint inhibitor. Immune checkpoint inhibitors are drugs that prevent cancer cells from switching off immune cells. This allows the immune system to find, unmask and destroy cancer cells. NOTE: This study is no longer enrolling.

Clinicaltrials.gov identifier: NCT03241745

GENetic Education Risk Assessment and TEsting Study (GENERATE)

The goal of the GENERATE study is to increase the uptake of genetic testing among family members of pancreatic cancer patients who may carry a genetic mutation.

This study involves education about genetic testing, undergoing genetic testing for cancer risk (for those who choose to) and completion of a series of 4 sets of questionnaires. Note: This study is no longer enrolling patients.

Clinicaltrials.gov identifier: NCT03762590

A Study in Advanced Breast Cancer Patients with BRCA 1/2 Mutations Evaluating Olaparib alone or in Combination with Atezolizumab

This is a study for women or men who have been diagnosed with advanced breast cancer with a BRCA 1/2 mutation. The goal of the study is to look at whether giving the PARP inhibitor olaparib in combination with the immunotherapy atezolizumab improves outcomes for patients compared to olaparib alone. NOTE: This study is no longer enrolling people.

Clinicaltrials.gov identifier: NCT02849496

Combination Chemotherapy With or Without Atezolizumab in Treating Patients With Stage III Colon Cancer and Deficient DNA Mismatch Repair

This study is no longer enrolling people.

Clinicaltrials.gov identifier: NCT02912559

USCF Helen Diller Family Comprehensive Cancer Center

PHACT Study: Population Health and Cancer Testing

NOTE: The PHACT study is no longer recruiting patients.

Pilot Study of Denosumab in BRCA1 or BRCA2 Mutation Carriers Scheduling Risk-Reducing Salpingo-Oophorectomy

The purpose of this study is to evaluate the effects of denosumab on ovarian cancer risk markers among premenopausal women with a BRCA1 or BRCA2 mutation, who are scheduled to undergo risk-reducing surgery to remove their ovaries and fallopian tubes. UPDATE: THIS STUDY HAS BEEN DISCONTINUED.

Clinicaltrials.gov identifier: NCT03382574

A Study in Hereditary Breast and Ovarian Cancer Families to Provide Men With Up To Date Information About the Personal Importance of Genetic Testing (GEM)

The Genetic Education for Men or GEM study, is a clinical trial evaluating educational tools for men from families in which a BRCA1/2 gene mutation has been identified. In order to identify untested men from BRCA1/2 families, we are seeking women who have received positive BRCA1/2 test results and have at least one untested male relative. NOTE: This study is no longer enrolling people.

Clinicaltrials.gov identifier: NCT02957981

A Phase 2 Study of Nivolumab in Combination with Either Rucaparib, Docetaxel, or Enzalutamide in Men with Castration-resistant Metastatic Prostate Cancer (CheckMate-9KD)

CheckMate-9KD is a clinical research study for men with metastatic prostate cancer (which means cancer that has spread) that no longer responds to treatments that lower testosterone. The purpose of this study is to compare three different combination therapies, each containing a drug called nivolumab and another anti-cancer drug. All three combination therapies are considered investigational, which means that they are not currently approved to treat men with metastatic prostate cancer. The study doctors want to learn more about which therapy is most effective in treating metastatic prostate cancer. NOTE: This study is no longer enrolling.

Clinicaltrials.gov identifier: NCT03338790

A Study in Ovarian Cancer Patients Evaluating Rucaparib and Nivolumab as Maintenance Treatment Following Response to Front-Line Platinum-Based Chemotherapy (ATHENA)

ATHENA is a study for women who are newly diagnosed with ovarian cancer. The goal of ATHENA is to look at whether giving maintenance therapy with different agents improves outcomes for women who have completed front-line treatment. UPDATE: THIS STUDY IS NO LONGER ENROLLING PATIENTS

Clinicaltrials.gov identifier: NCT03522246

Decision Navigation for Advanced Prostate Cancer Treatment Options Using mHealth

Men with advanced prostate cancer face difficult choices for treatment because of the nature of their disease and having limited options. This study will test the use of an innovative Registered Nurse-Community Patient Navigator team delivered interactive mHealth decision aid for patients with advanced prostate cancer to help facilitate informed shared decisions about anti-cancer treatment that affects their quality of life. NOTE: This study is no longer enrolling.

Clinicaltrials.gov identifier: NCT03327103

Safety and Efficacy of Olaparib Alone Or in Combination with Medication Targeting DNA Damaging Repair for Metastatic Triple Negative Breast Cancer

The purpose of this study is to learn the safety and effectiveness of the PARP inhibitor, olaparib as a single drug therapy compared with olaparib in combination with the new agent AZD6738 in patients with metastatic Triple-Negative Breast Cancer (TNBC). NOTE: This study is no longer enrolling people.

Clinicaltrials.gov identifier: NCT03330847

Olive Oil for High Risk Breast Cancer Prevention

This study will evaluate the effect of hydroxytyrosol, a component of olive oil, on breast density in women who are at high risk for developing breast cancer. UPDATE: THIS STUDY IS NO LONGER ENROLLING PATIENTS.

Clinicaltrials.gov identifier: NCT02068092

Auricular Point Acupressure to Self-Manage Aromatase Inhibitor Musculoskeletal Symptoms in Breast Cancer Survivors

Severe joint pain and muscle stiffness are common side effects of taking Aromatase Inhibitors. Aromatase inhibitor musculoskeletal symptoms have a negative effect on a woman's physical function and quality of life. Auricular point acupressure uses stimulation applied to points on the ear without using needles. This study will look at and test auricular (ear) point acupressure to manage aromatase-inhibitor-caused joint pain and muscle stiffness in breast cancer survivors.

Note: This study is no longer enrolling patients.

Clinicaltrials.gov identifier: NCT03697200

A Study to Evaluate Rucaparib in Combination With Other Anticancer Agents in Patients With a Solid Tumor (SEASTAR)

This study will look at how safe, effective and tolerable the oral PARP inhibitor Rucaparib is when used in combination with other anticancer agents in patients with advanced solid tumors, including triple-negative breast cancer, ovarian cancer or urothelial cancer. Note: This study has completed enrollment.

Clinicaltrials.gov identifier: NCT03992131

Study of Safety and Effectiveness of Motiva® Breast Implants

Note: This study is no longer enrolling.

Clinicaltrials.gov identifier: NCT03579901

Additional Results on Clinicaltrials.gov
1000 results

Clinical Trial	Official Title
NCT07121244	A Phase 1 Study of 68Ga-R11228 and 177Lu-R11228 in Breast Cancer
NCT07544589	A Phase 1 Study Evaluating DISP-10 in Participants With Advanced Gastrointestinal Cancers
NCT06826768	A Ph Ib Study of REGN5678 Plus Cemiplimab in Patients With mCRPC
NCT06479239	Study of EGFRBi Armed Fresh PBMC in Metastatic or Unresectable Pancreatic Cancer
NCT05890677	The LYMPH Trial - Microsurgical Versus Conservative Treatment of Chronic Breast Cancer Associated Lymphedema
NCT03287271	ROCKIF Trial: Re-sensitization of Carboplatin-resistant Ovarian Cancer With Kinase Inhibition of FAK
NCT06148298	Cell-Free DNA Chromatin Immunoprecipitation (ChIP) for Diagnosing Cancer
NCT05132504	Neoadjuvant Folfirinox Combined With Pembrolizumab Followed by Surgery for Patients With Resectable Pancreatic Cancer
NCT07024784	A Study to Assess Change in Disease Activity and Adverse Events in Adult Participants With Gynecologic Cancers Receiving Intravenous Infusion of IMGN151 as Monotherapy or in Combination With Other Therapies
NCT03322995	Pancreatic Cancer Adaptive Neoadjuvant Chemotherapy Trial
NCT06059963	A Prospective, Multi-center, Observational Study for Signal-C Test Evaluation
NCT06940271	Feasibility and Effect of Wrapping Nerves With a Multi-Layer Perinatal Tissue Allograft During Prostatectomy
NCT06898333	Implementation and Effectiveness of the BJC-Pink and Pearl Project on Lung Cancer Screening
NCT02600949	Personalized Peptide Vaccine in Treating Patients With Advanced Pancreatic Cancer or Colorectal Cancer
NCT06985238	Stratagen Quantitative Prostate MRI Platform Pilot Study
NCT06270043	Focal Therapy for Localized Prostate Cancer
NCT04071236	Radiation Medication (Radium-223 Dichloride) Versus Radium-223 Dichloride Plus Radiation Enhancing Medication (M3814) Versus Radium-223 Dichloride Plus M3814 Plus Avelumab (a Type of Immunotherapy) for Advanced Prostate Cancer Not Responsive to Hormonal Therapy
NCT05975593	MicroEnvironment Tumor Effects of Radiotherapy - Comprehensive Radiobiology Assessment TRial
NCT05888532	64Cu-GRIP B in Patients With Advanced Malignancies
NCT06706921	18F-Fluciclovine PET/CT Impact on Predicting Clinical Outcome of 177Lu-PSMA-617 Therapy in Patients With Prostate Cancer
NCT06401421	EXActDNA-003 / NSABP B-64: Study of Molecular Residual Disease Detection in Breast Cancer (MRD)
NCT05490472	JAB-2485 Activity in Adult Patients With Advanced Solid Tumors
NCT06258993	A Randomized Two-Arm Proof of Concept Study Testing A Novel Approach to Exercise Promotion Based on Affect-regulation
NCT06778863	A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
NCT05720338	Is Intraperitoneal Drainage Necessary Following Distal Pancreatectomy?
NCT03257033	Intra-arterial Gemcitabine vs. IV Gemcitabine and Nab-Paclitaxel Following Radiotherapy for LAPC
NCT06677190	Belzutifan in Recurrent Clear Cell Carcinoma of Gynecologic Origin
NCT04052048	Active Surveillance SNEP Assay Registry Trial for Prostate Cancer
NCT07203378	Nurturing Exercise Routine for Greater Improvement in Zest and Energy on Enhertu
NCT05190978	Randomized Feasibility Trial for Mesh in Pre-Pectoral Reconstruction
NCT03769415	Harnessing Analysis RNA Expression and Molecular Subtype to Optimize Novel TherapY MBCA
NCT04677816	Impact of Vitamin D Supplementation on the Rate of Pathologic Complete Response in Vitamin D Deficient Patients
NCT06366347	ALPINE: Maintenance Letrozole/Abemaciclib
NCT06616155	Ruxolitinib and Enzalutamide for the Treatment of Metastatic Castration-Resistant Prostate Cancer
NCT07220135	Trial of Neoadjuvant THP vs TCHP for HER2-Amplified/Positive Breast Cancer
NCT04548817	Neurocutaneous Melanocytosis Registry
NCT06526299	Low PSMA SUV Boost (LPS-Boost): Intensified 177Lu-PSMA-617 Treatment for Patients With Metastatic Castrate-Resistant Prostate Cancer With Low PSMA Expressing Disease
NCT00034216	Collection of Blood From Patients With Cancer
NCT06252649	Study of Sotorasib, Panitumumab and FOLFIRI Versus FOLFIRI With or Without Bevacizumab-awwb in Treatment-naïve Participants With Metastatic Colorectal Cancer With KRAS p.G12C Mutation
NCT01915225	Obtaining Solid Tumor Tissue From People Having Biopsy or Surgery for Certain Types of Cancer
NCT07424547	Phase I Study of SYS6043 in Patients With Advanced/Metastatic Solid Tumors
NCT04590326	A Study to Find Out How Safe REGN5668 is and How Well it Works In Adult Women When Given With Either Cemiplimab, or Cemiplimab + Fianlimab, or Ubamatamab
NCT03334708	A Study of Blood Based Biomarkers for Pancreas Adenocarcinoma
NCT07209176	Physician- and Patient-based Barriers to NGS Testing
NCT05683418	A Study to Evaluate the Safety and Tolerability of TOS-358 in Women With HR+ HER2- Breast Cancer
NCT05447923	Addressing Disparities in Colorectal Cancer Screening in Black and Underserved Phoenix Communities
NCT02620852	Women Informed to Screen Depending on Measures of Risk (Wisdom Study)
NCT03729115	A Multi-Modality Surveillance Program for Women at High Risk for Breast Cancer
NCT04575935	Minimally Invasive Surgery After Neoadjuvant Chemotherapy for the Treatment of Stage IIIC-IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer, LANCE Trial
NCT04915508	Extremely Hypofractionated Intensity Modulated Stereotactic Body Radiotherapy for the Treatment of Prostate Cancer With Rising PSA After Radical Prostatectomy
NCT04541108	Phase 0 Master Protocol for CIVO Intratumoral Microdosing of Anti-Cancer Therapies
NCT06391034	Magnetic Resonance (MR) Imaging With Hyperpolarized 13C-Pyruvate +/- 13C,15N-Urea in Patients With Prostate Cancer
NCT02757859	High Volume Washing of the Abdomen in Increasing Survival After Surgery in Patients With Pancreatic Cancer That Can Be Removed by Surgery
NCT07535541	A Feasibility Study of Biometric Measurements Via Wearable Smart Watch Technology for Evaluation of Vasomotor Symptoms in Patients Treated With Androgen Deprivation Therapy for Prostate Cancer (Prostate 007)
NCT03769766	Trial of Curcumin to Prevent Progression of Low-risk Prostate Cancer Under Active Surveillance
NCT05223322	Understanding and Addressing Disparities in Cancer Therapy Induced Inflammation and Associated Endothelial Dysfunction
NCT07023731	A Study to Evaluate ARV-806 in Adults With Advanced Cancer That Has the KRAS G12D Mutation
NCT06954831	Ultra-hypofractionated Whole Breast Irradiation With Lumpectomy Cavity Boost for the Treatment of Stage I-III Breast Cancer
NCT07491445	Study of Daraxonrasib and Daraxonrasib + GnP as First-line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma
NCT06802172	Effect of Meal Timing During Cancer Treatment in Patients in Alaska: A Randomized Clinical Trial
NCT07321106	A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Anti-tumor Activity of CBI-1214 T Cell Engager in Participants With Advanced or Metastatic MSS/MSI-L Colorectal Cancer
NCT07224815	cfDNA 5mC/5hmC Biomarkers to Predict Chemotherapy Response in Metastatic Colorectal Cancer
NCT06342440	Early Detection of Advanced Adenomas and Colorectal Cancer
NCT07020806	[68Ga]Ga DOTA-5G as a Diagnostic Imaging Agent for Metastatic/Advanced Invasive Lobular Breast Cancer (LBC)
NCT03861676	Image-guided Focal Brachytherapy Utilizing Combined 18F-DCFPyl PET/CT
NCT04567420	DNA-guided Second Line Adjuvant Therapy for High Residual Risk, Estrogen Receptor Positive, HER-2 Negative Breast Cancer (DARE)
NCT07278336	A Study to Assess Adverse Events, Change in Disease Activity and How Intravenous (IV) ABBV901 Moves Through the Body Alone or in Combination With Bevacizumab in Adult Participants With Ovarian Cancer
NCT06957691	Proof-of-Concept Trial to Assess the Efficacy and Safety of Fezolinetant in Improving Vasomotor Symptoms in Men With Prostate Cancer Undergoing Androgen Deprivation Therapy
NCT05969860	At-Home Cancer Directed Therapy Versus in Clinic for the Treatment of Patients With Advanced Cancer
NCT07235293	A Study to Test DSP107 in Combination With Atezolizumab in Comparison With Fruquintinib as a New Treatment for Colorectal Cancer.
NCT06129747	Repeat Breast Conserving Surgery Followed by Daily Partial Breast Irradiation in Ipsilateral Breast
NCT05972343	COOL-IT-PRO: Cryoablation of Breast Cancer in Non-surgical Patients
NCT06534125	Acutherapy to Prevent Aromatase Inhibitor-Associated Arthralgias in Non-Hispanic Black Postmenopausal Women With Early-Stage Breast Cancer
NCT04073706	Sentinel Node Biopsy in Endometrial Cancer
NCT04816006	Breast Cancer, Reasoning, and Activity Intervention
NCT06347068	Study of Autologous CAR-T Cells Targeting B7-H3 in TNBC iC9-CAR.B7-H3 T Cells
NCT05361798	A Phase II Study Evaluating T-Cell Clonality After Stereotactic Body Radiation Therapy Alone and in Combination With the Immunocytokine PDS01ADC in Localized High and Intermediate Risk Prostate Cancer Treated With Androgen Deprivation Therapy
NCT05488548	Dual BET and CBP/p300 Inhibitor in Patients With Targeted Advanced Solid Tumors and Hematological Malignancies
NCT07594015	Pembrolizumab and Lenvatinib in Mismatch Repair Proficient Recurrent Endometrial Cancer After Failure of First-Line Therapy With Platinum-based Doublet and Immunotherapy
NCT06444815	A Study of VET3-TGI in Patients With Solid Tumors
NCT05676255	The Breast Cancer Survivors and Partners Online Research Together (SUPORT) Project
NCT06130826	Immune Response Activation for the Treatment of Unresectable Metastatic Colorectal Cancer or CEA Positive Metastatic Breast Cancer
NCT05846789	SOC Chemotherapy +/- Tocilizumab for Triple Negative and ER-low Breast Cancers
NCT06230185	CtDNA Based MRD Testing for NAC Monitoring in TNBC
NCT07332455	First-Time-in-Human Study of GSK5471713 in Adults With mCRPC
NCT05239338	Preserving Fertility After Colorectal Cancer Study
NCT06904378	ONT01 and Gemcitabine/Nab-paclitaxel as Second Line Therapy for Metastatic Pancreatic Ductal Adenocarcinoma
NCT04048278	Lidocaine Infusion in Pancreatic Cancer
NCT05530655	A Study to Determine the Preferred Dose of the Drug, Lisinopril, for Preventing Urinary Toxicity Following Radiotherapy for Prostate Cancer
NCT06422455	Access to Genetic Testing in Underserved Patients With Cancer
NCT05130255	GD2-SADA:177Lu-DOTA Complex in Patients With Solid Tumors Known to Express GD2
NCT05989347	Study to Evaluate Biomarkers and Safety of Dapagliflozin Concomitant with Neoadjuvant Therapy
NCT04715958	SHAPE Neoadjuvant Chemotherapy Response
NCT05698576	TRANBERG® Transperineal MR/US Fusion Laser--Induced Thermal Therapy for Men With Prostate Cancer
NCT06879041	A Phase I Study of [225Ac]-AZD2284 in Patients With Metastatic Castration-Resistant Prostate Cancer
NCT05558241	Micro-UltraSound In Cancer - Active Surveillance
NCT06990542	Image-guided, Tumor-focused Radiotherapy Treatment in Intermediate and High-risk Prostate Cancer
NCT06462183	Study of Safety and Efficacy of RGT-61159 in Adults With Relapsed/Refractory Adenoid Cystic Carcinoma (ACC) or Colorectal Carcinoma (CRC)
NCT05478694	Outcomes of Focal Ablation for Prostate Cancer
NCT05491226	Reinvigorating TNBC Response to Immunotherapy With Combination Myeloid Inhibition and Radiation
NCT06675643	Digital Remote Monitoring of Immune Checkpoint Inhibitor Therapy Induced Toxicity Using the Vigilant App
NCT06887348	A Study to Assess the Long-term Safety Outcomes in Patients Previously Treated With RP1, RP2, or RP3
NCT05848141	Rowing Following Breast Cancer Chemotherapy
NCT04115254	Stereotactic Magnetic Resonance Guided Radiation Therapy
NCT07197554	A Phase 1/1B Study of ST-01156, a Small Molecule RBM39 Degrader, in Patients With Advanced Solid Malignancies
NCT06028022	Reishi Mushroom Extract for Fatigue and/or Arthralgias/Myalgias in Patients With Breast Cancer on Aromatase Inhibitors
NCT03551951	Tumor Cell and DNA Detection in the Blood, Urine, and Bone Marrow
NCT01950572	Tissue Procurement and Natural History Study of Patients With Malignant Mesothelioma
NCT00843375	Evaluation of Stool Based Markers for the Early Detection of Colorectal Cancers and Adenomas
NCT04196257	BP1001-A in Patients With Advanced or Recurrent Solid Tumors
NCT04789486	Nano-SMART: Nanoparticles With MR Guided SBRT in Centrally Located Lung Tumors and Pancreatic Cancer
NCT06665945	The SENTRY Study: Testing Whether Changes in Platelet RNA Enhance the Early Diagnosis of Ovarian Cancer
NCT05288777	Adjuvant Chemoradiation and Biomarkers of Response in High-risk Breast Cancer
NCT06746012	Designing a Dyad-Based mHealth Intervention to Improve Adherence to Lifestyle Recommendations in Colorectal Cancer Survivors and Their Family Caregivers
NCT06746428	Activity Coaching During Pelvic Radiation Therapy
NCT04852887	De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
NCT05620329	UNC Pleural Fluid Registry
NCT05787834	Home-based Respiratory Muscle Training for Minimizing Side Effects in Patients Undergoing Treatment for Breast Cancer
NCT04265872	Bortezomib Followed by Pembrolizumab and Cisplatin in metTNBC
NCT05922930	Study of TROP2 CAR Engineered IL15-transduced Cord Blood-derived NK Cells Delivered Intraperitoneally for the Management of Platinum Resistant Ovarian Cancer, Mesonephric-like Adenocarcinoma, and Pancreatic Cancer
NCT07085767	Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer
NCT03675893	RESOLVE: Abemaciclib + Letrozole +/- Metformin, Zotatifin, or Gedatolisib in Endometrial or Low-Grade Serous Ovarian Cancer
NCT03943316	Laboratory Study of Cancer & Immune Cells in Ascites Fluid of Ovarian Cancer Patients to Test Alternative Therapies
NCT05422794	Testing the Addition of Anti-Cancer Drug, ZEN003694 (ZEN-3694) and PD-1 Inhibitor (Pembrolizumab), to Standard Chemotherapy (Nab-Paclitaxel) Treatment in Patients With Advanced Triple-Negative Breast Cancer
NCT06026657	Gemcitabine and Ex Vivo Expanded Allogenic Universal Donor, TGFβi Natural Killer (NK) Cells With or Without Naxitamab (Danyelza) for the Treatment of Patients With Metastatic, GD2 Expressing, HER2 Negative Breast Cancer
NCT05053971	Testing A New Anti-cancer Drug Combination, Entinostat and ZEN003694, for Advanced and Refractory Solid Tumors
NCT06855277	Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC
NCT04291612	Observational Study of Women With Endometrial Cancer Who Receive the Standard Treatment for Their Disease
NCT02772367	Generation of Heart Muscle Cells From Blood or Skin Cells of Breast Cancer Patients
NCT07189871	177Lu-BetaBart in Patients With Relapsed/Refractory, Locally Advanced Inoperable, or Metastatic Solid Tumors
NCT06598007	A Study to Determine the Effect of CT3001 in Patients With Advanced Solid Tumors
NCT04646434	Brain and Pelvic Floor Muscle Activity of Patients Who Had or Are Undergoing Robot-Assisted Radical Prostatectomy
NCT05852041	rhPSMA-73 PET-MRI Imaging for the Detection of Prostate Cancer Among Men Who Are Otherwise Candidates for Active Surveillance
NCT07225036	Promoting Immunotherapy Efficacy With Low-Dose Liver RT
NCT07226856	BMS-986340 in Combination With Nivolumab, Gemcitabine and Nab-paclitaxel for the Treatment of Metastatic and Recurrent Pancreatic Adenocarcinoma
NCT03824145	Every Day Counts: A Lifestyle Program for Women With Metastatic Breast Cancer
NCT06134375	A Study of Tetrathiomolybdate (TM) Plus Capecitabine
NCT04084730	Study of 3-Day Partial Breast Radiation Therapy in Women With Breast Cancer
NCT04994067	Intra-Operative Radiation Registry
NCT07215000	Cleansing Options in Out-Patient Setting to Improve Tolerance (COOP SIT) Trial
NCT05417594	Study of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid Malignancies
NCT05287451	Risk Reducing Salpingectomy With Delayed Oophorectomy as an Alternative to Risk- Reducing Salpingo-oophorectomy in High Risk-Women to Assess the Safety of Prevention - US Cohort Study
NCT07546500	A Study of Azenosertib (ZN-c3) Versus Investigator's Choice Chemotherapy in Subjects With Platinum-Resistant High-Grade Serous Ovarian, Primary Peritoneal, or Fallopian Tube Cancers Positive for Cyclin E1 Protein Expression
NCT04683653	Study of Pelvic Hypofractionated Radiotherapy in Endometrial Cancer
NCT06954337	MATCH-UP: MAking Telehealth-Delivery of Cancer Care at Home Effective and Safe-Upscaled: A Pragmatic Cluster Randomized Trial
NCT05108298	Improving Adolescent and Young Adult Self-Reported Data in ECOG-ACRIN Trials
NCT06607458	Evaluation of the Safety and Efficacy of Treatment w/High Dose Melphalan Given Directly Into the Liver Followed by Treatment w/Approved Cancer Treatment or Approved Cancer Treatment Alone in Patients w/ Metastatic Colorectal Cancer w/Liver Dominant Disease
NCT04678648	A Trial of RSC-1255 for Treatment of Patients With Advanced Malignancies
NCT03919292	Neratinib + Valproate in Advanced Solid Tumors, w/Expansion Cohort in Ras-Mutated Ca
NCT05489211	Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)
NCT06326411	A Study to Investigate the Safety and Efficacy of NST-628 Oral Tablets in Subjects With Solid Tumors
NCT07447700	A Pilot Study to Evaluate the Effectiveness of Focused Massage on Pain, Mobility, and Quality of Life During Radiation Treatment for Patients With Breast Cancer
NCT06960798	Characterizing the Genomic Landscape of Prostate Cancer in Native American Populations (NAT-Geno)
NCT06153836	Neurotization of the Nipple Areolar Complex to Restore Sensation for Patients With Breast Cancer Undergoing Nipple Sparing Mastectomy and Reconstruction
NCT06205316	SBRT Versus Hypofractionated Radiotherapy for Biochemically Recurrent or Oligometastatic Prostate Adenocarcinoma
NCT05879926	Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
NCT07109427	Impact of an Electronic Health Record Maintenance Alert on PSA Screening Rates in a 10-Hospital Integrated Health System
NCT07405801	A Phase II Study Evaluating the Efficacy and Safety of Inavolisib Plus Ribociclib Plus Fulvestrant Versus Placebo Plus Ribociclib Plus Fulvestrant in Participants With Advanced Breast Cancer
NCT06504147	A Study of Radspherin® in Patients With Primary Advanced Epithelial Cancer, With Peritoneal Metastasis That Are Homologous Recombination Proficient Scheduled to Undergo Neoadjuvant Chemotherapy and Interval Debulking Surgery
NCT05080946	Using Aspirin to Improve Immunological Features of Ovarian Tumors
NCT07224724	Exosome-derived Extrahepatic Metastasis Detection By Liquid Biopsy In Colorectal Cancer Liver Metastases
NCT06042569	Dose-Reduced Docetaxel With Cyclophosphamide for the Treatment of Vulnerable Older Women With Stage I-III HER2 Negative Breast Cancer, the DOROTHY Trial
NCT03260842	Bio-Repository of High Risk Cohorts for the Early Detection of Pancreas Cancer
NCT06937996	Outcomes of Ablation of Unresectable Pancreatic Cancer Using the NanoKnife Irreversible Electroporation System-
NCT06984562	Adaptive Radiation for Locally Advanced Unresectable Pancreatic Cancer
NCT06112314	IMC-F106C Regimen Versus Nivolumab Regimens in Previously Untreated Advanced Melanoma (PRISM-MEL-301)
NCT06934538	First-in-human Trial of STC-1010, an Immunotherapy, in Patients With Unresectable Locally Advanced or Metastatic Colorectal Cancer
NCT07276438	Image-Guidance and Online Adaptation With Stereotactic Body Radiation Therapy for the Treatment of Localized Prostate Cancer, MANTICORE Trial
NCT06437574	Intensive Cholesterol-Lowering and CD8+ T Cells in Prostate Cancer
NCT05913713	HIIT Following Breast Cancer Chemotherapy
NCT04074135	Natural History and Management of Von Hippel-Lindau (VHL) Associated Pancreatic Neuroendocrine Tumors
NCT05974150	Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia Using Remote Symptom Monitoring
NCT03067051	Clinical Study to Assess the Safety and Efficacy of the SpectraCure P18 System
NCT02926729	Real-Time Assessment Of Breast Cancer Lumpectomy Specimen Margins With Nonlinear Microscopy
NCT03897270	Photoacoustic Imaging of the Breast in Patients With Breast Cancer and Healthy Subjects
NCT06906341	Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers
NCT05183828	Effect of HSD3B1 (1245C) Gene Mutation on Treatment of Stage I-III Breast Cancer
NCT05800665	A Study Evaluating the Safety, Pharmacokinetics, and Activity of RO7656594 In Participants With Advanced or Metastatic Prostate Cancer
NCT06657144	A Study of CHS-114 (Tagmokitug) in Combination With Toripalimab and/or Other Treatments in Participants With Advanced Solid Tumors
NCT04573231	Evaluation of PSMA in HER2- AR+ Metastatic Breast Cancer
NCT07028853	This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
NCT06965192	Designing Visual Tools to Enhance Cancer Surgeon Decision-making
NCT05379595	A Study of Amivantamab Monotherapy and in Addition to Standard-of-Care Chemotherapy in Participants With Advanced or Metastatic Colorectal Cancer
NCT05863195	Testing Pump Chemotherapy in Addition to Standard of Care Chemotherapy Versus Standard of Care Chemotherapy Alone for Patients With Unresectable Colorectal Liver Metastases: The PUMP Trial
NCT05234177	Tempus CRC Surveillance Study: A ctDNA Biomarker Profiling Study of Patients With CRC Using NGS Assays
NCT05535192	TeleHealth Resistance Exercise Intervention to Preserve Dose Intensity and Vitality in Elder Breast Cancer Patients
NCT02838836	Tumor Cell and DNA Detection in the Blood, Urine and Bone Marrow of Patients With Solid Cancers
NCT06171607	Contrast Enhanced Ultrasound Medical Imaging for Identifying Breast Masses
NCT05903131	Uterine Preservation Via Lifestyle Transformation
NCT07060807	A Clinical Study of Patritumab Deruxtecan to Treat Breast Cancer (MK-1022-016)
NCT05035836	A Phase 2 Single-Arm Open-Label Pilot Trial Evaluating Zanidatamab (ZW25) in Patients With Early Stage HER2/Neu Positive (HER2+) Breast Cancer (BC)
NCT06989437	A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
NCT05795101	TRUDI: TDXD+Durva in HER2+/Low IBC
NCT06938581	ERAS Protocols in Breast Conserving Surgery
NCT06673017	PTM-101 in Pancreatic Ductal Adenocarcinoma (PDAC)
NCT05086250	Feasibility Study of Oral Ketamine Versus Placebo for the Treatment of Anxiety in Patients With Pancreatic Cancer
NCT05128890	Evaluation of Resection Techniques for Pancreatic Tumors
NCT07007559	ASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in Metastatic HER2-Positive Breast Cancer
NCT05797168	Phase I/IIa Study of AZD5335 as Monotherapy and Combination Therapy in Participants With Solid Tumors
NCT06805825	A Study of the c-Kit Specific Antibody-Drug Conjugate NN3201 for Advanced and/or Metastatic Solid Tumors Known to Express c-Kit
NCT06764940	A Pivotal Phase II Clinical Trial of Utidelone Injection Plus Capecitabine in HER2-negative Breast Cancer Patients With Brain Metastases
NCT04725903	Proton Radiation Therapy for the Treatment of Patients With High Risk Prostate Cancer
NCT06371768	Symptom Management and Transitioning to Engagement With Post-treatment Care for Adolescent and Young Adult Cancer Survivors
NCT06389097	SPECT Imaging for Pharmacokinetics and dosimEtry Towards TREATment Optimization
NCT05458674	Tucatinib+Trastuzumab+Eribulin in HER2+ MBC
NCT05168618	Cabozantinib and Atezolizumab for the Treatment of Metastatic Castration-Resistant Prostate Cancer
NCT05616650	Focal Therapy With Stereotactic Body Radiation Therapy (SBRT) for Patients With a Single Prostate Tumor
NCT06411691	KRAS-Targeted Vaccine Combined With Balstilimab and Botensilimab for Patients With Stage IV MMR-p Colorectal Cancer and Pancreatic Ductal Cancer
NCT05563220	Open-Label Umbrella Study To Evaluate Safety And Efficacy Of Elacestrant In Various Combination In Participants With Metastatic Breast Cancer
NCT05776524	Study of Amplitude-Modulated Radiofrequency Electromagnetic Fields in Metastatic Pancreatic Cancer
NCT03495427	PSMA-PET Imaging for Detecting Early Metastatic Prostate Cancer in Men w/ High Decipher Test Scores
NCT06804785	Hybrid Intelligence for Trustable Diagnosis and Patient Management of Prostate Cancer (HIT-PIRADS)
NCT06245889	PET Dynamics to Response-Adapted Neoadjuvant Therapy in TNBC
NCT04683679	A Study of Radiation Therapy With Pembrolizumab and Olaparib or Other Radiosensitizers in Women Who Have Triple-Negative or Hormone-Receptor Positive/Her2 Negative Breast Cancer
NCT05514717	A Study of XMT-2056 in Advanced/Recurrent Solid Tumors That Express HER2
NCT07231159	Building on Trust: Navigating Preventive Lung, Breast, and Prostate Cancer Screenings at Community Resource Spots
NCT06990880	A Study of GSK5458514 Administered Alone or In Combination With Other Anti-Cancer Agents in Participants With Prostate Cancer
NCT04751435	Developing New Educational Materials About Genetic Testing for a Diverse Group of Cancer Patients
NCT07488676	A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors
NCT06650579	REVELUTION-2: Relugolix+Abiraterone Acetate (AA) Versus Leuprolide+AA Cardiac Trial
NCT07118176	Determining the Biodistribution of an Imaging Tracer (68Ga-FAPi-46) in Patients With Solid Tumors or Hematologic Cancers
NCT07040891	A Pilot Trial of "Just ASK™" to Increase Discussions About Breast Cancer Clinical Trials
NCT06672497	Near Infrared Spectroscopy (NIRS) as a Method for Measuring Oxidative Capacity of Skeletal Muscle Mitochondria in Breast Cancer and All Gynecological Cancer Patients
NCT06265285	Comparison of In-Home Versus In-Clinic Administration of Subcutaneous Nivolumab Through Cancer CARE (Connected Access and Remote Expertise) Beyond Walls (CCBW) Program
NCT03935893	Adoptive Transfer of Tumor Infiltrating Lymphocytes for Advanced Solid Cancers
NCT06470243	Testing Whether the Addition of Carboplatin Chemotherapy to Cabazitaxel Chemotherapy Will Improve Outcomes Compared to Cabazitaxel Alone in People With Castrate-Resistant Prostate Cancer That Has Spread Beyond the Prostate to Other Parts of the Body
NCT06867484	Breast Re-irradiation After Second Ipsilateral Lumpectomy
NCT06726148	Study of ECI830 Single Agent or in Combination in Patients With Advanced HR+/HER2- Breast Cancer and Other Advanced Solid Tumors
NCT03449238	Pembrolizumab And Stereotactic Radiosurgery (Srs) Of Selected Brain Metastases In Breast Cancer Patients
NCT07478185	Prehab for Pancreatic Cancer Surgery
NCT03743298	Safety of AV-MEL-1 With Anti-PD-1 Therapy in Metastatic Melanoma
NCT05704647	Phase II Study of Nivolumab in Combination With Relatlimab in Patients With Active Melanoma Brain Metastases
NCT05806814	Sipuleucel-T Based Autologous Cellular Immunotherapy for Advanced Prostate Cancer
NCT07386444	Inspiratory Muscle Training for Breast Cancer Patients on Chemotherapy
NCT06698458	Alpha Radiation Emitters Device (DaRT) With Chemotherapy for the Treatment of Locally Advanced and Metastatic Pancreatic Cancer
NCT07517198	Dose Determining Study of EXS74539 (REC-4539) in Participants With Select Solid Tumors
NCT04751396	Testing of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint Inhibitors
NCT07504796	ctDNA-guided Addition of Ipilimumab to Patients Receiving Nivolumab and Relatlimab
NCT06511141	Sacral Neuromodulation for Male Overactive Bladder (MOAB)
NCT07166094	Study to Assess the Efficacy and Safety of Rina-S Compared to Treatment of Investigator's Choice in Participants With Endometrial Cancer
NCT03492151	Confocal Laser Endomicroscopy as an Imaging Biomarker for the Diagnosis of Pancreatic Cystic Lesions
NCT04332588	Monitoring HER2+ Breast Cancer Neoadjuvant Treatment With Advanced PET/MRI
NCT07112053	A Vaccine (STEMVAC) With Standard Endocrine-Based Therapy or Chemotherapy for the Treatment of Metastatic Hormone Receptor Positive, HER2 Negative Breast Cancer
NCT05077137	A Feasibility Study Utilizing Immune Recall to Increase Response to Checkpoint Therapy
NCT06751329	A Study of DM002 in Patients With Advanced Solid Tumors
NCT05464082	Functional Precision Oncology to Predict, Prevent, and Treat Early Metastatic Recurrence of TNBC
NCT06099769	A Study of Enzalutamide, Enzalutamide in Combination With Mifepristone, or Chemotherapy in People With Metastatic Breast Cancer
NCT07402473	Optimize Neoadjuvant Therapy in HER2-Positive Early-Stage Breast Cancer
NCT03213041	Pembrolizumab and Carboplatin in Treating Patients With Circulating Tumor Cells Positive Metastatic Breast Cancer
NCT07317505	A Phase 1 Study of JMT108 in Participants With Advanced Solid Tumors
NCT04794322	Developing a Test of Uterine Lavage for the Detection of Ovarian Cancer
NCT06353321	Non-significant Risk (NSR) Study of [68Ga]-PSMA-11 (Illuccix) as a BgRT BioGuide on RefleXion X1
NCT05225428	Video Education With Result Dependent dIsclosure
NCT04700332	PyL in Patients With High Risk and Biochemically Recurrent Prostate Cancer
NCT06549465	Study Evaluating Dosimetry, Randomized Dose Optimization, Dose Escalation and Efficacy of Ac-225 Rosopatamab Tetraxetan in Participants With PSMA PET-Positive Castration-Resistant Prostate Cancer (CRPC)
NCT06666192	The Ohio State University (OSU) SCREEN Community Program
NCT04389281	X-ray Psoralen Activated Cancer Therapy in Head and Neck, Breast, Sarcoma and Melanoma
NCT06627244	Study of Tebentafusp and Radioembolization in the Treatment of Metastatic Uveal Melanoma
NCT05468034	Exercise in Metastatic Breast Cancer: EMBody
NCT06099093	Pilot of 18F-DCFPyL-PSMA PET in mCRPC Patients Receiving 117Lu-Vipivotide Tetraxetan
NCT05064098	Interpretations and Predictions of Patient Reported Outcomes by Breast Cancer Patients
NCT06533644	A Study of SYNC-T Therapy SV-102 in Participants With Metastatic Castration-Resistant Prostate Cancer
NCT07319195	Window Study of Intratumoral Mitazalimab in Breast Cancer (WINIT-BC)
NCT06343077	Intratumoral and Systemic Hiltonol® (Poly-ICLC) in Prostate Cancer Patients on Active Surveillance
NCT04075305	The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study
NCT04503265	A Trial of AMXI-5001 for Treatment in Patients With Advanced Malignancies
NCT05827081	Phase IIIb Study of Ribociclib + ET in Early Breast Cancer
NCT04423211	Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
NCT07140900	Study Evaluating the Safety, Tolerability, and Efficacy of Xaluritamig in Combination With Androgen Receptor Pathway Inhibitors in Participants With Metastatic Hormone-sensitive Prostate Cancer
NCT06305312	Community Services Navigation to Advance Health Equity in Breast Cancer Screening
NCT02016248	SBRT Boost for Unfavorable Prostate Cancer'
NCT05766891	Opioid-Sparing Effects of Nurse-Delivered Hypnosis During Breast Cancer Surgery
NCT07122713	Definitive Radiation Therapy for Inoperable Breast Cancer
NCT05929820	Impact of Protect Your Colon™ on CRC Screening
NCT05020860	Correlation of Clinical Response to Pathologic Response in Patients With Early Breast Cancer
NCT06400550	Identification of Metabolic Phenotypes Associated With Melanoma Metastasis
NCT03175224	APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors
NCT05123482	A Phase I/IIa Study of AZD8205 Given Alone or Combined, in Participants With Advanced/Metastatic Solid Malignancies
NCT06361940	Molecular Analyses to Predict Pathways of Endocrine Resistance Following Short Term Neoadjuvant Endocrine Treatment in Patients With Hormone Receptor-Positive HER2-negative Breast Cancer
NCT07197723	Study of How People Make Decisions About Prostate Cancer Risk
NCT07506876	Concurrent Neoadjuvant Chemo/Endocrine Therapy in HER2+ Breast Cancer
NCT07155317	Time-of-Day Specified Immunotherapy for Advanced Melanoma, The TIME Trial
NCT06040541	Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
NCT07524322	Study of RGT-490 in Patients With PIK3CA-Mutated Advanced Solid Tumors
NCT06925724	A Study of Ivonescimab in People With Endometrial and Cervical Cancers
NCT06067841	A Study to Assess BMS-986460 in Participants With Metastatic Castration-resistant Prostate Cancer
NCT05548296	A Phase 2 Study of ACR-368 in Endometrial Adenocarcinoma
NCT07542041	Artidis Nanomechanical Signature Profiling of Pancreatic Cancer Specimens
NCT05576896	Hydroxychloroquine in Combination With Encorafenib and Cetuximab or Panitumumab in the Treatment of Metastatic BRAF-mutated Colorectal Cancer Refractory
NCT05556473	F-Tryptophan PET/CT in Human Cancers
NCT06173362	Abiraterone and Prednisone or Darolutamide for the Treatment of Advanced Prostate Cancer
NCT06785441	Older Men's Decision Making About Active Surveillance for Prostate Cancer - Aim 3: Decision Aid Efficacy Testing
NCT05129605	Prostate Cancer Genetic Risk Evaluation and Screening Study
NCT02021604	Fluorodopa F 18 in Congenital Hyperinsulinism and Insulinoma
NCT05534438	A Study on Adding Precisely Targeted Radiation Therapy (Stereotactic Body Radiation Therapy) to the Usual Treatment Approach (Drug Therapy) in People With Breast Cancer
NCT05501704	ETHAN - ET for Male BC
NCT06059118	Difluoromethylornithine and High Dose Testosterone With Enzalutamide in Metastatic Castration-Resistant Prostate Cancer
NCT04969315	TT-10 (PORT-6) and TT-4 (PORT-7) as Single Agents and in Combination in Subjects With Advanced Selected Solid Tumors
NCT04697576	Intralesional Influenza Vaccine for the Treatment of Stage I-IV Melanoma
NCT06833255	A Post-treatment Supportive Service Program for the Transition Into Survivorship for Black Women Breast Cancer Survivors in Western New York
NCT07044310	5-strain Probiotic Formulation in HR-positive Breast Cancer Receiving Aromatase Inhibitor to Prevent Bone Loss
NCT05837455	NeoTAILOR: ABiomarker-directed Approach to Guide Neoadjuvant Therapy for Patients With Stage II/III ER-positive, HER2-negative Breast Cancer
NCT06915025	Phase 3 Trial Evaluating the Safety & Efficacy of IMNN-001 Administered in Combination w/ Standard NACT & Adjuvant Chemotherapy in Newly Diagnosed Patients w/ Advanced EOC, Fallopian Tube or Primary Peritoneal Cancer
NCT04967976	Breast Mesh Used in Two-staged Breast Reconstruction
NCT06161025	A Study of Raludotatug Deruxtecan (R-DXd) in Subjects With Platinum-resistant, High-grade Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
NCT04038502	Carboplatin or Olaparib for BRcA Deficient Prostate Cancer
NCT05677802	Feasibility Study of Biobehavioral Stress Reduction Intervention in Patients With Triple Negative Breast Cancer
NCT00451022	Follow-Up Study of Subjects Previously Enrolled in Poxviral Vector Gene Transfer Studies
NCT04739072	Minimal Residual Disease Assessment in Patients With Colorectal Cancer, the MiRDA-C Study
NCT03321045	Positron Emission Tomography (PET) Imaging With Zirconium-89 (89Zr)-Trastuzumab for Prediction of HER2 Targeted Therapy Effectiveness
NCT03701581	4-aminopyridine Treatment for Nerve Injury
NCT05377996	A Study of XMT-1660 in Participants With Solid Tumors
NCT06614192	A Study Assessing Adverse Events and Disease Activity When Comparing Intravenously (IV) Infused ABBV-400 to Trifluridine and Tipiracil (LONSURF) Oral Tablets Plus IV Infused Bevacizumab in Adult Participants With c-Met Protein Above Cutoff Level Above Refractory Metastatic Colorectal Cancer
NCT07141121	Feasibility of Timesaving When Using Histolog Confocal Laser Endomicroscopy for Margin Assessment in Prostatectomy Specimen
NCT05608252	VS-6766+Abema+Fulv in Met HR+/HER- BC
NCT05200559	T-regulatory Cell Depletion with E7777 Combined with Pembrolizumab in Recurrent or Metastatic Solid Tumors
NCT00477100	Biospecimen and Medical Data Collection and Tumor Biopsy in Creating Research Tissue Registry in Patients With Inflammatory or Invasive Breast Cancer
NCT07463599	Safety and Efficacy of Tegavivint in Patients With Metastatic Colorectal Carcinoma
NCT05754749	Comparison of CE-DBT and MRI in Patients With Known Breast Lesions
NCT05838716	Vitamin D for Prostate Endocrine Therapy
NCT05391126	GENOCARE: A Prospective, Randomized Clinical Trial of Genotype-Guided Dosing Versus Usual Care
NCT04348747	Dendritic Cell Vaccines Against Her2/Her3 and Pembrolizumab for the Treatment of Brain Metastasis From Triple Negative Breast Cancer or HER2+ Breast Cancer
NCT03351348	Bupivacaine vs Placebo for Unilateral Mastectomy Surgical Site Post-operative Pain Control
NCT06634875	Isunakinra Alone and in Combination With Pembrolizumab in Patients With Colorectal Cancer (MSS)
NCT06674811	Biomarkers of Resiliency In Childhood Cancer Surgery
NCT05914987	Determining Individualized Cancer Therapy in Pancreatic Cancer
NCT07416552	A Study to Investigate CEA-PRIT 2.0 in Participants With Metastatic Colorectal Cancer (mCRC)
NCT06355336	Real World Prostate Cancer Registry
NCT07361614	Pilot Testing of a Colorectal Cancer Education Program
NCT07318558	A Clinical Trial of Sac-TMT in People With Non-HRD Positive Advanced Ovarian Cancer (MK-2870-021)
NCT06408298	HCQ in Resectable Localized Prostate Cancer
NCT04362826	Study to Investigate Efficacy of a Novel Probiotic on the Bacteriome and Mycobiome of Breast Cancer
NCT07164443	A Study of Pasritamig Versus Placebo in Late Line Metastatic Castration-resistant Prostate Cancer (mCRPC)
NCT06450873	Turkey Tail Mushroom for Treating Post-Menopausal Women With HER2-Negative ER-Positive Breast Cancer Undergoing Surgery
NCT06288113	Re-treatment With 177Lu-PSMA-617 for the Treatment of Metastatic Castration-Resistant Prostate Cancer, RE-LuPSMA Trial
NCT05487846	Peer Navigation for the Support of Metastatic Prostate Cancer Patients Undergoing Genetic Evaluation
NCT05005403	Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan
NCT05902988	A Phase I/II Study of VLS-1488 in Subjects With Advanced Cancer
NCT06636682	FK-PC101 as Adjuvant Therapy for Men With High-Risk Prostate Cancer
NCT00001823	Evaluation for NCI Surgery Branch Clinical Research Protocols
NCT07283705	A Phase II Study Evaluating BMS-986504 in MTAP-deleted Pancreatic Cancer
NCT04489719	Impact of DNA Repair Pathway Alterations on Sensitivity to Radium-223 in Bone Metastatic Castration-resistant Prostate Cancer
NCT07319871	A Study of Pasritamig (JNJ-78278343) in Combination With JNJ-86974680 for Treatment of Prostate Cancer
NCT07270237	A Study of Multiparametric Ultrasound Imaging Methods
NCT05765500	RecoverPC: Relugolix vs GnRH Agonist in Quality of Life
NCT06465966	UFPTI 2403-PR12: Real-Time Volumetric Ionizing Radiation Acoustic Imaging for In-vivo Proton Treatment Monitoring in Pencil-Beam Scanning
NCT05950945	Trastuzumab Deruxtecan (T-DXd) in Patients Who Have Hormone Receptor-negative and Hormone Receptor-positive HER2-low or HER2 IHC 0 Metastatic Breast Cancer
NCT07148128	Phase 1/2a Study to Assess the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of WEF-001 as Monotherapy in Advanced KRAS-Mutant Solid Tumours.
NCT06386887	Fasting During Neoadjuvant Chemotherapy in Patient With Epithelial Ovarian Cancer
NCT05042687	Comparative Performance of Molecular Breast Imaging (MBI) to Magnetic Resonance Imaging (MRI) of the Breast in Identifying and Excluding Breast Carcinoma in Women at High Risk for Breast Cancer
NCT06315595	Improvements in Dynamic Contrast-Enhanced MR Angiography and Perfusion and Non-Contrast MRI
NCT04692675	Multiparametric Magnetic Resonance Imaging of the Prostate to Assess Disease Progression and Genomics in Patients Undergoing Active Surveillance for Prostate Cancer
NCT05739981	Phase II IMNN-001 (Also Known as GEN-1) on SLL With BEV and NACT, Newly Diagnosed Advanced Ovarian, Fallopian Tube or Primary Peritoneal Cancer
NCT07198724	ERADICATE: A Phase Ib/II Study of Elacestrant Plus Trastuzumab Deruxtecan in Patients With CDK4/6 Inhibitor and Endocrine-resistant HR+/HER2-low or HER2-ultralow Metastatic Breast Cancer
NCT05568680	SynKIR-110 for Mesothelin Expressing Ovarian Cancer, Cholangiocarcinoma or Mesothelioma
NCT03463954	Confirmatory Clinical Evaluation of Novilase® Laser Therapy for Focal Destruction of Malignant Breast Tumors
NCT06381154	Photoradiation With Verteporfin to Facilitate Immunologic Activity of Pembrolizumab in Unresectable, Locally Advanced or Metastatic Pancreatic Cancer
NCT06085729	Phase I/II Study of PEGylated Arginine Deiminase (ADI-PEG20) With Carboplatin and Cabazitaxel in Men With Aggressive Variant Prostate Cancers (AVPC)
NCT07006727	Phase I Study of [225Ac]Ac-ETN029 in Patients With Advanced DLL3-expressing Solid Tumors
NCT06678269	A Study of Abemaciclib and Radiation Therapy in People With Metastatic Breast Cancer
NCT06843551	The Miami "EMPIRE" Trial - Eradication of Metastatic Pancreatic Cancer With Immuno-Radiation
NCT02594202	Care of the Prostate Cancer Patient and Prospective Procurement of Prostate Cancer Tissue
NCT02775461	Pancreas Registry and High Risk Registry
NCT06681233	Feasibility Study of CBCT for IGRT in Cancer Patients
NCT06880055	Shield Post-Approval Study Protocol
NCT07033026	An Evaluation of NGM120 in a Randomized, Double-blind, Placebo-controlled Study in Participants With Colorectal Cancer Who Have Cancer Cachexia.
NCT07408089	Study of the Kinesin Oral Molecular Degrader BBI-940 in Subjects With Advanced or Metastatic Breast Cancer
NCT06293898	Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
NCT06271291	Pancreatic Cancer Detection Consortium (PCDC) Prospective Cohorts
NCT07505797	ATUSA Ultrasound Diagnostic Imaging for Breast Lesions Evaluation (AUDIBLE)
NCT07186296	EXoPERT EMERALD Clinical Study
NCT07555210	Pilot Study of Bone Mineral Density Changes During Anti-PD-1 Immunotherapy
NCT07047872	A 3D-Printed External Breast Prosthesis for the Improvement of Patient-reported Outcomes Among Breast Cancer Patients That Underwent a Mastectomy Without Reconstruction
NCT07120100	Transcranial Magnetic Stimulation for Chemotherapy-Induced Peripheral Neuropathy in Breast and Gynecologic Cancer Survivors
NCT06305598	Bipolar Androgen Therapy to Restore Sensitivity to Androgen Deprivation Therapy for Patients With Metastatic Castration Resistant Prostate Cancer
NCT07058012	A Phase II Platform Study to Evaluate Treatment With Cemiplimab Monotherapy or Cemiplimab Plus Fianlimab or Other Novel Combinations in Patients With Colorectal Cancer With Minimal Residual Disease Following Definitive Surgery and Chemotherapy (EMPIRE)
NCT05327465	Exercise to Enhance Cardiovascular Health Among Black Prostate Cancer Patients With Androgen Deprivation Therapy
NCT05942300	CPI-0209 Plus Carboplatin in Patients With Platinum Sensitive Recurrent Ovarian Cancer
NCT05053230	A Study Evaluating the Integrative Medicine at Home (IM@HOME) Program in People With Cancer
NCT06412198	A Multicenter Phase 1b/2 Study of Adagrasib, Cetuximab, and Cemiplimab for Metastatic Colorectal Cancer Harboring KRAS G12C Mutations
NCT04275557	Using Radiogenomics to Predict Malignant Potential of Intraductal Papillary Mucinous Neoplasms of the Pancreas
NCT06885034	A Study to Test the Safety and Effectiveness of GSK5764227, Alone or With Other Treatments, in Participants With Advanced Gastrointestinal Cancers That Cannot be Surgically Removed
NCT05612347	Colonoscopy vs Stool Testing for Older Adults With Colon Polyps
NCT05592626	A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
NCT04752826	BI-1808 as a Single Agent and With Pembrolizumab (KEYTRUDA® ) in Treatment of Advanced Malignancies(Keynote-D20)
NCT07153016	LEgal Guidance and AdvocaCY for CAREgivers (LEGACY CARE): A Pilot Clinical Trial for Caregivers of Persons With Colorectal Cancer
NCT05053555	High Dose-Rate Brachytherapy for the Treatment of Both Primary and Secondary Unresectable Liver Malignancies
NCT04516447	A Study of Azenosertib (ZN-c3) in Patients With Ovarian Cancer
NCT05030038	Oral Aromatase Inhibitors Modify the Gut Microbiome
NCT05665738	Two-fraction HDR Monotherapy for Localized Prostate Cancer
NCT03604315	Serial Imaging of the Novel Radiotracer [^18F] FLuorthanatrace ([^18F] FTT) by PET/CTF
NCT05704062	Quantitative MRI Assessment of Breast Cancer Therapy Response
NCT05381103	PSMA-PET to Guide Prostatectomy
NCT07087054	Carcinoid Syndrome Efficacy Study Featuring an Oral Daily Paltusotine Regimen
NCT04134260	Testing the Addition of the Drug Apalutamide to the Usual Hormone Therapy and Radiation Therapy After Surgery for Prostate Cancer, INNOVATE Trial
NCT06312124	A Study of Opportunistic Salpingectomy to Prevent Ovarian Cancer
NCT06882746	A Study to Test Different Doses of BI 765049 in People With Advanced Cancer of the Colon, Rectum, Stomach, or Pancreas
NCT03995082	Breast Cancer Patient Engagement With Patient Reported Outcome Measure Survey
NCT06445062	Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors
NCT05746897	A First-in-human, Phase I, Open-label, Multicenter Study of NM1F(Anti-PVRIG) in Patients With Advanced Solid Tumors
NCT01050504	Collecting and Studying Blood and Tissue Samples From Patients With Locally Recurrent or Metastatic Prostate or Bladder/Urothelial Cancer
NCT06418204	Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
NCT06903468	Novel Cavity Marking Technique in Breast Cancer Patients Undergoing Breast Conservation Surgery With Oncoplastic Reconstruction for the Delivery of Adjuvant Radiotherapy and Accuracy of Recommended Re-excisions
NCT04891068	BRE-04: Window of Opportunity Trial of Preoperative Low Dose Azacitidine in High-Risk Early Stage Breast Cancer
NCT06885697	Anti-Mesothelin TNaive/SCM hYP218 (TNhYP218) CAR T Cells in Participants With Mesothelin-Expressing Solid Tumors Including Mesothelioma
NCT07227168	A Study of STRO-004 in Adults With Refractory/Recurrent Metastatic Cancer
NCT05896189	Cognitive Training for Cancer Related Cognitive Impairment in Breast Cancer Survivors
NCT05136196	BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study
NCT06953882	Impact of Omitting Chemo Based on Patient's Selection for ER-Positive, HER2-Negative Breast Cancer With Ribociclib and Endocrine Therapy
NCT07071896	A Prospective Study of Video-assisted Exercise Program for the Breast Cancer Survivors
NCT07226427	A First-in-Human Study of MEN2501 in Participants With Platinum-Resistant Ovarian Cancer
NCT02918474	Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer
NCT06101290	Locally Ablative TherapY in Oligo-ProgressiVe GEnitourinary TumoRs (LAYOVER)
NCT06472661	FUSA With Intratumoral PolyICLC in Regionally Advanced Resectable Melanoma
NCT07020117	A Study of [225Ac]Ac-AKY-1189 in Patients With Solid Tumors
NCT07130708	Exploring the Potential of Robotic Telesurgery in Remote Settings
NCT05037825	The Gut Microbiome and Immune Checkpoint Inhibitor Therapy in Solid Tumors
NCT05467891	Ribociclib And Endocrine Treatment of Physician's Choice for Locoregional Recurrent, Resected Hormone Receptor Positive HER2 Negative Breast Cancer
NCT06682650	Implementation of a ColoRectal Cancer Screening Tool in US Primary Care Practices - Usual Quality Improvement (10 Clinics) vs Normalization Process Theory-Participatory Learning in Action (10 Clinics)
NCT05313191	Prospective Evaluation of Pencil Beam Scanning Proton Therapy for Previously Irradiated Tumors
NCT05115474	Study of Screening Brain MRIs in Stage IV Breast Cancer
NCT07280312	Ultrasound Microvessel Imaging for the Evaluation of Ovarian and Adnexal Lesions
NCT07354919	Axelopran for Advanced Cancer in Patients Receiving Opioids
NCT07136077	A Phase 2 Trial of Fruquintinib and Tislelizumab in ctDNA-defined Minimal Residual Disease in Colorectal Cancer After Completion of Adjuvant Chemotherapy
NCT05112601	Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma
NCT06617481	PET Scan Study to Detect Prostate Cancer in Patients with Early PSA Recurrence
NCT07219277	Clinical Validation of Early Detection Blood Test for Universal Large-scale Breast Cancer Screening
NCT06728072	Addition of Antibiotics to Upfront Treatment Regimen for Colorectal Cancer
NCT07227077	Dosing Physical Activity Among Older Cancer Survivors Who Experience Chronic Pain: a Micro-randomized Trial
NCT06896162	PROGRESS: Precision Oncology Using Genomic Reflexive Evaluations for Study Selection and Survival
NCT03933670	Hyperpolarized Pyruvate (13C) MR Imaging in Monitoring Patients With Prostate Cancer on Active Surveillance
NCT06103669	Locally AblatiVe TherApy in OLigO-pRogressive SOlid TUmorS (VALOROUS)
NCT02945579	Multicenter Trial for Eliminating Breast Cancer Surgery or Radiotherapy in Exceptional Responders to Neoadjuvant Systemic Therapy
NCT06518746	Gonadal Dysgenesis Tissue Cryopreservation for Fertility Preservation
NCT05932862	A Phase 1 Study of XL309 (ISM3091) Alone and in Combination in Participants With Advanced Solid Tumors
NCT04658303	Evolution of Metabolic and Immune Dysfunction in In-transit Melanoma
NCT02706561	Helping Men Adhere to Sexual Rehabilitation Following Prostate Cancer Surgery
NCT05463796	InAdvance: Surveillance, Prevention, and Interception in a Population at Risk for Cancer
NCT06339827	ASk Questions in GYnecologic Oncology (ASQ-GYO)
NCT05384496	Axitinib and Nivolumab for the Treatment of Mucosal Melanoma
NCT07044362	Histotripsy Plus Chemotherapy vs Chemotherapy Alone for Advanced Colorectal Liver Metastasis
NCT06447662	A Study to Learn About the Study Medicine PF-07934040 When Given Alone or With Other Anti-cancer Therapies in People With Advanced Solid Tumors That Have a Genetic Mutation.
NCT05930483	Remotely Delivered, Community-Aligned Weight Loss Interventions Among Breast Cancer Survivors, ¡Vida! Trial
NCT06454383	Gemcitabine and Leflunomide in Patients With Advanced Unresectable Pancreatic Cancer
NCT05721976	With Love, Grandma ("Con Cariño, Abuelita") Pilot Study
NCT04959474	Pre-operative SABR With and Without Caloric Restriction for Early Stage Breast Cancer
NCT04890613	Study of CX-5461 in Patients With Solid Tumours and BRCA1/2, PALB2 or Homologous Recombination Deficiency (HRD) Mutation
NCT06291324	WATD and Cancer-Related Fatigue: A Study For Patients Undergoing Anti-Cancer Treatment
NCT07033689	Feasibility Study of Suizenji, in Patients With Unresectable Pancreatic Ductal Adenocarcinoma (SUNRISE-II)
NCT07042243	The Florida ASCENT Study
NCT05386108	Study of Abemaciclib and Elacestrant in Participants With Brain Metastasis Due to ER+/HER-2- Breast Cancer
NCT06276491	Phase 1, Safety and Tolerability Study of XmAb541 in Advanced Solid Tumors
NCT03322891	Improving Health Literacy in African-American Prostate Cancer Patients
NCT05959291	Discontinuation of Maintenance HER-2 Directed Therapy in Long-Term Survivors of Metastatic HER-2 Positive Breast Cancer
NCT06595160	Determining the Link Between Dietary Patterns, Fecal Microbiome and Response to Neoadjuvant Chemotherapy
NCT06111313	The University of Miami Adapt (UAdapt) Trial
NCT03424850	Safety and Efficacy of 21 Gy, 23 Gy and 25 Gy for High Dose Rate (HDR) Prostate Brachytherapy
NCT06974110	Study of Orally Administered MOMA-341 in Participants With Advanced or Metastatic Solid Tumors
NCT06616597	Trial Targeting Gut Bacterial Androgen Production to Reverse Therapeutic Resistance to Abiraterone in Patients With Metastatic Prostate Cancer
NCT06507618	Pre-Operative Window of ET to Inform RT Decisions (POWER II)
NCT04339374	Ultrasound and Photoacoustic Imaging for Enhanced Differential Diagnosis of Rectal Cancer
NCT06585410	Study of Intralesional Cemiplimab in Adult Patients With Early Stage Cutaneous Squamous Cell Carcinoma
NCT06953245	Collecting Patient-Reported Experiences With Radiation Dermatitis in Breast Cancer Patients Undergoing Radiotherapy
NCT07341503	The Sleep After Breast Cancer (ABC) Study - Examining Sleep Changes and Biomarkers Among Breast Cancer Patients
NCT06302595	MRI Guided Prostate Biopsy
NCT07022483	Study of Trastuzumab Deruxtecan Versus Standard of Care Chemotherapy for HER2-Expressing (IHC 3+/2+) Endometrial Cancer
NCT04924075	Belzutifan/MK-6482 for the Treatment of Advanced Pheochromocytoma/Paraganglioma (PPGL), Pancreatic Neuroendocrine Tumor (pNET), Von Hippel-Lindau (VHL) Disease-Associated Tumors, Advanced Gastrointestinal Stromal Tumor (wt GIST), or Solid Tumors With HIF-2α Related Genetic Alterations (MK-6482-015)
NCT04553770	Trastuzumab Deruxtecan Alone or in Combination With Anastrozole for the Treatment of Early Stage HER2 Low, Hormone Receptor Positive Breast Cancer
NCT07114601	A Study of LY4257496 in Participants With Cancer (OMNIRAY)
NCT06788886	Breathing Practice for Brain and Mental Health in Cancer and Neurodegenerative Diseases
NCT06695845	A Phase 2 Study of Zanidatamab in Patients With HER2-expressing Tumors
NCT05633654	Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)
NCT01102556	PANCREATIC DISEASE COHORT A Registry and Biospecimen Bank to Better Understand Pancreatic Disease
NCT07079631	A Clinical Study to Test if an Investigational Treatment Called BNT314 When Used in Combination With Another Investigational Treatment BNT327 and Chemotherapy, is Beneficial and Safe for Patients With Advanced Colorectal Cancer
NCT04485286	Evaluation of PET Probe [68Ga]CBP8 in the Detection of Radiation Induced Tissue Injury
NCT06555588	Engage Psychosocial Intervention for Cancer Symptoms
NCT06849544	Phase II Trial to Investigate the Safety and Efficacy of Four Dosing Regimens of OTL78 Injection
NCT06295744	Outcomes and Cosmesis With Whole Breast Irradiation and Boost
NCT02393703	Interrogation of Exosome-mediated Intercellular Signaling in Patients With Pancreatic Cancer
NCT05732623	Exogenous and Endogenous Risk Factors for Early-onset Colorectal Cancer
NCT06923527	Circulating Tumor DNA
NCT07066189	Lifestyle, Exercise, And Nutrition (LEAN) Trial on Pathologic Complete Response in TNBC
NCT05735080	Open-Label Study to Evaluate the Safety, Tolerability, PK, and Efficacy of INX-315 in Patients With Advanced Cancer
NCT05629546	Memory-Like Natural Killer Cells With Nivolumab and Relatlimab in Advanced or Metastatic Melanoma After Progression on Checkpoint Inhibitors
NCT04796818	An Investigational Scan (Intravoxel Incoherent Motion Diffusion Weighted Imaging) for the Evaluation of Colorectal Cancer Liver Metastases Treatment Response
NCT05134779	De-convoluting Interactions Between Genes, the Cancer Environment, and the Immune System to Develop Therapies That Work for You
NCT04766190	DISCO: A Patient Intervention to Reduce the Financial Burden of Cancer
NCT03474913	Upright MRI for Prostate Cancer Screening
NCT04485013	TTX-080 HLA-G Antagonist in Subjects With Advanced Cancers
NCT07046585	Evaluation of the Natera Colorectal Cancer Screening Test in an Average Risk Population (FIND-CRC)
NCT06036810	Spanish Decision Tool for Ovarian Cancer Maintenance Therapy
NCT06281678	A Study of IBI363 in Subjects with Advanced Solid Malignancies
NCT06638307	A First-in-Human Study of MEN2312 in Adults With Advanced Breast Cancer
NCT04847063	Individual Response to Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Treatment of Peritoneal Carcinomatosis From Peritoneal Mesothelioma or Atypical Mesothelial Proliferation or From Ovarian, Colorectal, or Appendiceal Histologies
NCT07202247	Metabolic Interventions (Time-Restricted Eating, GLP1 Receptor Agonist, and Heart Healthy Diet) to Improve Cardiometabolic Health in Prostate Cancer Patients During Androgen Deprivation Therapy, IMPACT-ADT Trial
NCT07222215	PhII Randomized CAPecitabine + ELAcestrant vs. Capecitabine Alone in ER+ Breast Cancer (CAPELA)
NCT06860815	Cemiplimab and Transarterial Radioembolization With Y-90 SIR-S Spheres for the Treatment of Liver Directed Metastatic Breast Cancer
NCT05967533	The Immune Effects of Fermented Wheat Germ Nutritional Supplementation in Patients With Advanced Solid Tumor Cancers Being Treated With Standard of Care Checkpoint Inhibitors
NCT07173101	Clinical Investigation of the Effects of Semiconductor Embedded Therapeutic Garments on Cancer-related Cognitive Impairment in Breast and Gynecological Cancer Patients
NCT06625034	Radiation Therapy With RapidPlan Knowledge-based Planning vs Human-Driven Planning for Treatment of Prostate Cancer
NCT06557733	An Investigational Drug (TPST-1495) in Patients With Familial Adenomatous Polyposis
NCT06063928	Confronting Cancer as a Community
NCT06745804	Study of 68Ga-R10602
NCT04486352	A Study of Targeted Agents for Patients With Recurrent or Persistent Endometrial Cancer
NCT04990921	Study of Palliative Radiation Combined with Pembrolizumab in Unresectable Metastatic Stage IV Breast Cancer
NCT05275075	Identify microRNAs in Cachexia in Pancreatic Carcinoma
NCT06072781	A Study of Avutometinib (VS-6766) + Defactinib (VS-6063) in Recurrent Low-Grade Serous Ovarian Cancer
NCT06772181	A Digital Health Intervention to Improve Symptoms and Physical Activity During Breast Radiation
NCT04792463	Frequency and Clinical Phenotype of BAP1 Hereditary Predisposition Syndrome
NCT07100106	A Study to Evaluate the Effect of GDC-4198 Alone and in Combination With Giredestrant Versus Abemaciclib and Giredestrant in Participants With Locally Advanced or Metastatic Estrogen Receptor-Positive (ER+), Human Epidermal Growth Factor Receptor-Negative (HER2-) Breast Cancer
NCT07011576	A Study of Fruquintinib Plus FOLFIRI as Second-Line Treatment for Participants With Metastatic Colorectal Cancer (mCRC)
NCT06730750	A Study of BMS-986490 With or Without Bevacizumab in Advanced Solid Tumors
NCT04305834	Abemaciclib and Endocrine Therapy in Older Patients With Breast Cancer.
NCT04665947	First-in-human Study of the Theranostic Pair [68Ga]Ga DOTA-5G and [177Lu]Lu DOTA-ABM-5G in Pancreatic Cancer
NCT07100847	Periprostatic Neurolysis in Prostate Cancer
NCT06215508	Geriatric Assessment and Technology Evaluation in Prostate Cancer
NCT07540572	A Study to Investigate the Safety, Pharmacokinetics, and Preliminary Efficacy of IDE574 Therapy in Adult Participants With Advanced Solid Tumors
NCT04895709	A Study of BMS-986340 as Monotherapy and in Combination With Nivolumab or Docetaxel in Participants With Advanced Solid Tumors
NCT06022822	Placebo-Controlled Trial of Urolithin A Supplementation in Men With Prostate Cancer Undergoing Radical Prostatectomy, URO-PRO Trial
NCT06388122	DiviTum®TKa: A Biomarker Assay for Efficacy in HR+ Metastatic Breast Cancer Patients
NCT07140172	Axillary Radiotherapy or Axillary Lymph Node Dissection in Patients With Clinically Node- Positive Breast Cancer Undergoing Upfront Tailored Axillary Surgery
NCT05396612	Role of the Immune Environment in Response to Therapy in Breast Cancer
NCT03524430	RNA Disruption Assay (RDA)-Breast Cancer Response Evaluation for Individualized Therapy
NCT05669430	A Study of GV20-0251 Monotherapy and GV20-0251 in Combination With Pembrolizumab in Participants With Solid Tumor Malignancies
NCT04858334	APOLLO: A Randomized Phase II Double-Blind Study of Olaparib Versus Placebo Following Curative Intent Therapy in Patients With Resected Pancreatic Cancer and a Pathogenic BRCA1, BRCA2 or PALB2 Mutation
NCT07214298	Pegcetacoplan in Combination With Modified FOLFIRINOX for the Treatment of Metastatic Pancreatic Ductal Adenocarcinoma
NCT07360314	Anti-Ly6E Exatecan ADC M7437 in Advanced Solid Tumors
NCT06051695	A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression
NCT05114798	Time-restricted Eating Versus Daily Continuous Calorie Restriction on Body Weight and Colorectal Cancer Risk Markers
NCT03954431	High-Resolution Lower Dose Dedicated Breast Computed Tomography (CT)
NCT06075953	DCIS: RECAST Trial Ductal Carcinoma In Situ: Re-Evaluating Conditions for Active Surveillance Suitability as Treatment
NCT05315700	Study of ORIC-114 in Patients With Advanced Solid Tumors Harboring an EGFR or HER2 Alteration
NCT03492671	Testing the Combination of Two Approved Chemotherapy Drugs and Radiation Prior to Surgery in Localized Pancreatic Cancer
NCT04797039	MRI-Guided Cryoablation for Focal Native Prostate Cancer
NCT06961357	Clinical Trial of CD40L-augmented TIL for Patients With Advanced Melanoma
NCT07136181	Evaluation of the Safety, Efficacy, and Pharmacokinetics of NBM-BMX in Patients With Metastatic Uveal Melanoma
NCT05726292	A Study of Enzalutamide Plus the Glucocorticoid Receptor Antagonist Relacorilant Versus Placebo for Patients With High-risk Localized Prostate Cancer
NCT05517811	Pre- and Post-operative TEG Indices in Patients With or Without Adenocarcinoma Undergoing Surgical Resection
NCT05630794	Testing for Safety and Colorectal Cancer Preventive Effects of ONC201
NCT06092892	IIT2023-09-Chung-UpfrontTAD: Upfront TAD/SNB in Patients With Breast Cancer With Nodal Metastases
NCT05873192	Presurgical Phase II Study of Talazoparib in Combination With Enzalutamide in Prostate Cancer
NCT06349642	Immune Checkpoint Inhibitor Response in Solid Tumors Using a Live Tumor Diagnostic Platform
NCT06991556	An Open-label Study of JSB462 (Luxdegalutamide) in Combination With Abiraterone in Adult Male Patients With Metastatic Hormone-sensitive Prostate Cancer (mHSPC)
NCT04657068	A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
NCT06441890	BRE-10: Biomarker Optimization of Neoadjuvant Therapy in Breast Cancer
NCT07015190	Neoadjuvant Darovasertib in Primary Uveal Melanoma
NCT07446322	FOLFIRI and Bevacizumab With or Without Pelareorep for Second-Line Treatment of Metastatic RAS-Mutated, Microsatellite-Stable Colorectal Cancer
NCT03937453	A Pancreatic Cancer Screening Study in Individuals With New-Onset or Deteriorating Diabetes Mellitus
NCT07185165	An Investigational Scan (Flotufolastat F 18 PET/CT) for Detecting Residual or Recurrent Disease in Patients Who Completed Focal Therapy for Prostate Cancer.
NCT07348367	A Comparison of Radical Prostatectomy and Precision Prostatectomy in Low- and Intermediate-risk Prostate Cancers.
NCT06623396	A Study of Mesothelin-Targeted CAR T-Cell Therapy in People With Esophagogastric Cancer
NCT05238922	Study of INCB123667 in Subjects With Advanced Solid Tumors
NCT07535112	A Study to Learn More About How Safe BAY 3771249 is and How Well it Works in People With Advanced or Metastatic Colorectal Cancer That Has a KRAS G12D Mutation
NCT04888975	A Non-randomized, Open-Label Study to Evaluate the Safety and Effectiveness of the Dayspring Technology for Patients With Breast Cancer Related Lymphedema (BCRL) After Lymphatic Surgery
NCT06855654	Promoting Resilience in Women With Breast Cancer (PRISM -MBC)
NCT06440005	A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors
NCT06562192	Phase I Study of [177Lu]Lu-NNS309 in Patients With Pancreatic, Lung, Breast and Colorectal Cancers
NCT01042548	Proteomics and Radiomics Research of Breast Cancer Markers in Tissue, Interstitial Fluid and Serum
NCT06945315	SAFE Nerve Sparing Guided by Micro-ultrasound (MUS)
NCT06764485	A Study to Compare the Efficacy and Safety of BMS-986365 Versus the Investigator's Choice of Therapy in Participants With Metastatic Castration-resistant Prostate Cancer
NCT06767462	An Ophthalmic Safety Study in Patients With Breast Cancer
NCT06515470	Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of BTX-9341 in Advanced and/or Metastatic Breast Cancer
NCT05054413	Formulating Expert Consensus Guidelines in Cancer Care Using the Delphi Method
NCT06917079	BBO-11818 in Adult Subjects With KRAS Mutant Cancer
NCT06123988	Prolonged Overnight Fasting and/or Exercise on Fatigue and Other Patient Reported Outcomes in Women With Hormone Receptor Positive Advanced Breast Cancer
NCT06800313	A Study of HLD-0915 in Patients With Metastatic Castration Resistant Prostate Cancer (mCRPC)
NCT07137468	Everyday Exposures: How Chemicals and Weight Impact Breast Cancer Risk
NCT02000089	The Cancer of the Pancreas Screening-5 CAPS5)Study
NCT04969835	A Study Evaluating the Safety, Pharmacokinetics and Early Efficacy of AVA6000 in Solid Tumours
NCT05465941	PLX038 for Treatment of Metastatic Platinum-resistant Ovarian, Primary Peritoneal, and Fallopian Tube Cancer
NCT06673329	Brodalumab in the Treatment of Immune-Related Adverse Events
NCT06708429	Lynch Syndrome X-Talk of Enteral Mucosa With Immune System
NCT04175431	Prostate Specific Membrane Antigen (PSMA) or (FACBC) PET/CT Site-Directed Therapy for Treatment of Prostate Cancer, Flu-BLAST-PC Study
NCT03127631	A RAndomizeD Intervention for Cardiovascular and Lifestyle Risk Factors in Prostate Cancer Patients
NCT06705686	Novel ACK1 Inhibitor (R)-9b in Patients With Prostate Cancer
NCT06609005	A Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Antitumor Activity of INV-9956 in Adult Patients With Advanced Metastatic Castration Resistant Prostate Cancer
NCT07120945	Hugo™ Robotic-Assisted Surgery (RAS) System in Gynecological Subjects (Embrace Gynecology)
NCT07254910	Feasibility of a Multi-Channel Intervention to Promote Colorectal Cancer Screening Among American Indians in Oklahoma
NCT07186842	A Clinical Trial to Test if the Investigational Drug BNT329 is Safe and Potentially Beneficial for People With Advanced Solid Tumors Known to Express the Tumor Marker CA19-9
NCT05130801	A Study of Multiparametric MRI and pHLIP® ICG in Breast Cancer Imaging During Surgery
NCT06365619	Neoadjuvant Ipilimumab/Nivolumab for Patients With Recurrent, High Risk, Resectable Melanoma
NCT06500455	Testing Longer Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With Cancer That Has Spread to the Brain
NCT06710067	Urine Metabolites in the Diagnosis of Disease
NCT04119024	Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors
NCT03025256	Intravenous and Intrathecal Nivolumab in Treating Patients With Leptomeningeal Disease
NCT03539822	Cabozantinib Plus Durvalumab With or Without Tremelimumab in Patients With Gastroesophageal Cancer and Other Gastrointestinal Malignancies
NCT07018869	Evaluating Whether an Educational Website Called Current Together After Cancer (CTAC) Improves Follow-up Care for Colorectal Cancer Survivors
NCT05703178	Web-based Pain Coping Skills Training for Breast Cancer Survivors With AI-Associated Arthralgia
NCT07182279	Neoadjuvant High Dose Rate Brachytherapy Prior to Radical Prostatectomy in Patients With Prostate Cancer
NCT05029999	CD40 Agonist, Flt3 Ligand, and Chemotherapy in HER2 Negative Breast Cancer
NCT01913106	HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer
NCT00040352	Clinical, Laboratory, and Epidemiologic Characterization of Individuals and Families at High Risk of Melanoma
NCT07383649	Trial to Study Anti- HCMV Therapy in Breast Cancer Patients With Progressive Intracranial Metastases and CMV Infection
NCT04778449	Quality of Life, Lifestyle, and Psychosocial Factors in Patients With Melanoma
NCT03526835	A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors
NCT01416714	Tissue Procurement for Gastric Cancer, Gastrointestinal Stromal Tumors (GIST), Esophageal Cancer, Pancreas Cancer, Hepatocellular Cancer, Biliary Cancer, Neuroendocrine, Peritoneal Mesothelioma, Anal Cancer and Colorectal Cancer in Patients Undergoing Surgery or Biopsy
NCT05573126	Phase 1/2 Study to Evaluate EP0062 as Monotherapy and in Combination in Patients With Advanced or Metastatic AR+/HER-2-/ER+ Breast Cancer
NCT06817226	BREAST Choice Decision Tool R21 - AIM2
NCT07548164	Comparing Two Different Boost Approaches in Radiation Therapy for People With Prostate Cancer
NCT06982521	Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
NCT06876714	ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Trastuzumab
NCT06205849	Intra-tumoral Mitazalimab (CD40 Antibody) With Irreversible Electroporation (IRE) in Locally Advanced Pancreas Cancer
NCT05733000	CPI-613 (Devimistat) in Combination With Hydroxychloroquine and 5-fluorouracil or Gemcitabine in Treating Patients With Advanced Chemorefractory Solid Tumors
NCT05554328	Testing the Use of the Combination of Selumetinib and Olaparib or Selumetinib Alone Targeted Treatment for RAS Pathway Mutant Recurrent or Persistent Ovarian and Endometrial Cancers, A ComboMATCH Treatment Trial
NCT06568016	A Clinic-wide Intervention (Primary Care-GI Connect) for Improving Rates of Colonoscopy After Abnormal Fecal Immunochemical Test Result in Patients at Federally Qualified Health Centers
NCT07581184	A Study of [225Ac]Ac-AKY-2519 in Patients With Metastatic Castration-Resistant Prostate Cancer
NCT06564571	Artificial Intelligence in Endoscopic Ultrasound
NCT06993844	Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors
NCT05667532	The C-MERIT Screening Cohort: Contrast-enhanced Mammography for Breast Cancer Screening and Risk Assessment in Women With Dense Breasts
NCT06274047	PROSTATE-IQ: Parallel RandOmized STudy of Personalized Apalutamide Treatment and Evaluation to Improve Quality of Life in Post-Operative Radiation With Androgen Axis Suppression. A Phase III Multi-center Study for Men With Detectable PSA After Prostatectomy for Prostate Cancer.
NCT06314958	Stage II/III Colorectal Cancer Recurrence
NCT06771544	Metronomic Cyclophosphamide With Pembrolizumab in Checkpoint Inhibitor Refractory Melanoma
NCT06100263	Breast Cancer Resiliency Through Exercise Program (B-REP)
NCT06260033	Stereotactic Body Radiation Therapy and FES PET/CT Imaging for the Treatment of Oligoprogressive Estrogen Receptor Positive Metastatic Breast Cancer
NCT06296147	Virtual Reality Headset and/or Aromatherapy for Patients Undergoing a Transperineal Prostate Biopsy
NCT06843447	A Clinical Study of Raludotatug Deruxtecan in People With Ovarian Cancer (MK-5909-003)
NCT06820463	A Study to Evaluate the Adverse Events, and Efficacy of Intravenous (IV) of Telisotuzumab Adizutecan in Combination With IV Oxaliplatin, Fluorouracil, Folinic Acid/Leucovorin, Bevacizumab, Panitumumab in Adult Participants With Metastatic Colorectal Cancer
NCT06720987	A Study to Investigate the Safety and Efficacy of KQB365 as Monotherapy and in Combination in Participants With Advanced Solid Malignancies
NCT04130516	Study Assessing MTD, Safety, Tolerability, PK and Anti-tumor Effects of LNS8801alone and With Pembrolizumab
NCT06806930	Predicting Response to Neoadjuvant Endocrine Therapy (Neo-PREDICT)
NCT05673200	Testing the Addition of an Anti-cancer Drug, ASTX727 (Cedazuridine, Decitabine), to Chemotherapy (Paclitaxel) and Immunotherapy (Pembrolizumab) for Metastatic Triple-Negative Breast Cancer
NCT07213804	A Two-Part Phase 3 Study of Sofetabart Mipitecan (LY4170156) in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Part B) Ovarian Cancer
NCT07558733	Sapanisertib and Serabelisib (PIKTOR) in Various Combinations in Patients With HR+/HER2- Advanced/Metastatic Breast Cancer
NCT06247995	A Phase I/II, Dose Finding and Optimization Study of [177Lu]Lu-NeoB in Combination With Capecitabine in Patients With GRPR+, ER+, HER2- Metastatic Breast Cancer After Progression on Previous Endocrine Therapy in Combination With a CDK4/6 Inhibitor.
NCT04923178	A Multi-Center Natural History of Urothelial Cancer and Rare Genitourinary Tract Malignancies
NCT05454488	An Evidence-Based Focal Cryotherapy Protocol for Focal Ablation of Intermediate Risk Prostate Cancer
NCT04157127	Th-1 Dendritic Cell Immunotherapy Plus Standard Chemotherapy for Pancreatic Adenocarcinoma
NCT07164027	Comparing a New PSMA Imaging Agent to MRI for Detecting Prostate Cancer, BEACON Trial
NCT03418961	S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity
NCT06397703	ADT and SBRT vs SBRT Alone for Unfavorable Intermediate Risk Prostate Cancer
NCT05568420	A Study of the Possible Effects of Medication on Young Onset Colorectal Cancer (YOCRC)
NCT07018986	The MIND-BC Study: MIND Diet for Breast Cancer Cognition
NCT07417488	GUCY2C Prime-Boost Vaccination for Advanced Colorectal and Small Bowel Adenocarcinomas
NCT05687123	Testing the Addition of Sunitinib Malate to Lutetium Lu 177 Dotatate (Lutathera) in Pancreatic Neuroendocrine Tumors
NCT06492759	High Dose Radiation Therapy With Pembrolizumab and Chemotherapy for the Treatment of Patients With PD-L1 Positive Metastatic Triple Negative Breast Cancer
NCT05979610	Using Reiki Therapy to Improve Symptoms Associated With Brachytherapy in Patients With Gynecological Malignancies
NCT06151223	A Prospective Registry for Patients at High-Risk for Pancreatic Cancer
NCT04796220	Focused Ultrasound and Gemcitabine in Breast Cancer
NCT06503146	18F-Fibroblast Activation Protein Inhibitor ([18F]FAPI-74) PET Imaging for Cancer Detection
NCT06106477	Impact of Intermittent Fasting on Biomarkers of Inflammation and Health-Related Quality of Life: A Feasibility Trial for Women With HR+/HER2- Early Breast Cancer
NCT06972875	Fezolinetant for Treating Hot Flashes in Men With Prostate Cancer
NCT07221357	A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Bevacizumab in Combination With Chemotherapy in Participants With Previously Untreated, Unresectable, or Metastatic Colorectal Cancer
NCT07127003	ILR to Prevent BRCL_MCC 23608
NCT07470853	A Study of MUC16-Directed Antibody Drug Conjugate HWK-016 in Participants With Advanced Solid Tumors.
NCT06500169	Golf Recreational Exercise for Enhanced Survivorship in Prostate Cancer Survivors
NCT06188520	A First-in-human Dose Escalation and Expansion Study to Evaluate the Safety, and Tolerability of AZD8421 Alone or in Combination in Participants With Selected Advanced or Metastatic Solid Tumors
NCT07406282	A Study to Learn About Real-world Utilization and Outcomes of Darolutamide and Other Androgen Receptor Pathway Inhibitors (ARPIs) for Newly Diagnosed Metastatic Hormone-sensitive Prostate Cancer (de Novo mHSPC) in US Urology Clinics
NCT06833866	Phase I Trial of 5-Fluorouracil (5FU) -Based Therapy in Combination With Hydroxytyrosol (HT) in Patients With Advanced or Metastatic Colorectal Cancer
NCT05913388	GB1211 and Pembrolizumab Versus Pembrolizumab and Placebo in Patients With Metastatic Melanoma and Head and Neck Squamous Cell Carcinoma
NCT05919329	Evaluation of the Change in PSMA Expression in Prostate Cancer in Response to Hormonal Therapy
NCT05496829	IMPACT Trial: Intervention to iMProve AdherenCe Equitably
NCT06488378	Phase Ib Study of Axatilimab in Combination With Olaparib in BRCA1/2 and PALB2- Associated Metastatic HER2-negative Breast Cancer
NCT01776905	In Vivo Real-time Detection of Circulating Melanoma Cells
NCT07128355	Botensilimab, Balstilimab, and SBRT in Colorectal Cancer
NCT06738303	Cabazitaxel +/- Carboplatin vs 177Lu-PSMA-617 in Metastatic Castrate-resistant Prostate Cancer
NCT06819007	Study of Trastuzumab Deruxtecan With Bevacizumab Versus Bevacizumab Monotherapy for First-line Maintenance in HER2-Expressing Ovarian Cancer (DESTINY-Ovarian01)
NCT04812366	Genomic Biomarker-Selected Umbrella Neoadjuvant Study for High Risk Localized Prostate Cancer
NCT06100705	Sipuleucel-T Combined With Bipolar Androgen Therapy in Men With mCRPC
NCT04872166	A Study of BTX-A51 in People With Advanced Solid Tumor and Breast Cancer
NCT07318051	Sample Collection for Ongoing Research and Product Evaluation Study
NCT06673095	Narrow Excision Versus Wide Excision for the Treatment of Adults With Invasive Cutaneous Melanoma, ICEMAN Trial
NCT07121972	Mirai-MRI: Validation of AI Models for Breast Cancer Risk
NCT07184957	Prospective Database of Clinical Outcomes Following Cryotherapy for Ablation of Clinically Localized Prostate Cancer
NCT07173751	ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer
NCT06799065	First-in-Human Study of ATX-295, an Oral Inhibitor of KIF18A, in Patients With Advanced or Metastatic Solid Tumors, Including Ovarian Cancer
NCT06748222	E-Mindfulness Approaches for Living After Breast Cancer
NCT07077239	Prostate Cancer Postoperative Stereotactic Body Radiotherapy With Adaptive Technology for Minimizing Toxicity
NCT05766371	Pembrolizumab Plus 177Lu-PSMA-617 in Patients With Castration Resistant Prostate Cancer
NCT06235151	Copper Cu 64 PSMA I&T PET Imaging in Men With Newly Diagnosed Prostate Cancer
NCT05768139	First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
NCT07258407	A Clinical Trial Evaluating the Safety of TD001 In Patients With PSMA-Expressing Metastatic Prostate Cancer
NCT03608631	iExosomes in Treating Participants With Metastatic Pancreas Cancer With KrasG12D Mutation
NCT07162194	MRI-Based Machine Learning Approach Versus Radiologist MRI Reading for the Detection of Prostate Cancer, The PRIMER Trial
NCT04360330	SABER Study for Selected Early Stage Breast Cancer
NCT06972628	Treatment of Patients With Progressive mCRPC With 177Lu-PSMA-617
NCT06435351	Personalized Dendritic Cell Vaccine Pilot for High Risk TNBC After Neoadjuvant Therapy
NCT04861077	Monitoring Breast Cancer Immunotherapy Treatment With Advanced Positron Emission Tomography Magnetic Resonance Imaging (PET/MRI)
NCT06297265	Manual Lymphatic Drainage Breast Massage in Breast Cancer Patients After Breast Conserving Surgery
NCT05933395	Genetically-informed Therapy for ER+ Breast Cancer Post-CDK4/6 Inhibitor
NCT07011654	Study of Naxitamab and Sacituzumab Govitecan in Patients With Metastatic Triple-negative Breast Cancer (TNBC)
NCT06632977	Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial
NCT07587957	Exploring the Feasibility of an Exercise and Noninvasive Brain Stimulation Intervention in Breast Cancer Survivors
NCT05498792	Study of CBL0137 in Combination With Ipilimumab and Nivolumab Therapy in Melanoma
NCT07276529	Initial Safety of SFM Plus OTOLoc for Creating Side-to-side or End-to-side Colorectal Anastomoses
NCT06795529	Targeted Palliative Care Intervention for Patients With Metastatic Breast Cancer
NCT06179303	Functional Imaging in Prediction of Response to Abemaciclib for Advanced Hormone Receptor-Positive, HER2-Negative Breast Cancer
NCT06525766	Adaptive Therapy With Capecitabine for Treatment of Metastatic ER Positive, HER2 Negative Breast Cancer
NCT07214779	Study to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
NCT06218303	Prototype DAA/TAA Vaccine Targeting MUC1 for Immune Interception and Prevention in Ductal Carcinoma In Situ
NCT04329494	PIPAC for the Treatment of Peritoneal Carcinomatosis in Patients With Ovarian, Uterine, Appendiceal, Colorectal, or Gastric Cancer
NCT04919629	APL-2 and Pembrolizumab Versus APL-2, Pembrolizumab and Bevacizumab Versus Bevacizumab Alone for the Treatment of Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer and Malignant Effusion
NCT05379153	Testing Laser Therapy for Treatment of Vaginal Dryness in Survivors of Breast Cancer, The Revitalize Trial
NCT06269978	Intraperitoneal Oxaliplatin and Fluorouracil for the Treatment of Patients With Peritoneal Metastases From Colorectal Cancer
NCT06660420	Phase 1 Dose Escalation and Expansion Study of PRAME T Cell Receptor (TCR) Engineered NK Cells in Participants With Recurrent and/or Refractory Melanoma (PRAMETIME-Mel)
NCT07307664	Increasing Germline Genetic Testing for Patients With Cancer
NCT01205815	Storage and Research Use of Human Bio-specimens From Melanoma Patients and Clinical Testing for Assignment of Treatment
NCT06635980	Hypofractionated Radiotherapy Before or After Breast Surgery for Treatment of Patients With Non-Metastatic Breast Cancer
NCT02749474	Maternal Cancer Diagnosis and Treatment During Pregnancy:a Database for Maternal, Fetal, and Neonatal Outcomes
NCT07076485	Shortening Adjuvant Photon and Proton Irradiation (SAPPHIRe-II): A 4 Cohort, Randomized, Phase II Multi-center Trial Evaluating Shorter Schedules of Adjuvant Regional Nodal Irradiation Among Women and Men With Node-positive and High-risk Node-negative Invasive Breast Cancer
NCT03451383	Older Breast Cancer Patients: Risk for Cognitive Decline
NCT06239194	Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors
NCT06745895	Multilevel Action Toward Colorectal Cancer and Hepatitis C Education and Screening
NCT06004661	Study of Lutetium (177Lu) Vipivotide Tetraxetan in mCRPC Participants With Moderately and Severely Impaired and With Normal Renal Function
NCT04291651	UCSF PANC Cyst Registry
NCT06580002	Repurposing Riluzole for Cancer-Related Cognitive Impairment: A Pilot Trial
NCT02960022	A Study for Subjects With Prostate Cancer Who Previously Participated in an Enzalutamide Clinical Study
NCT03972657	A Trial to Find Out if REGN5678 (Nezastomig) is Safe and How Well it Works Alone or in Combination With Cemiplimab for Adult Participants With Metastatic Castration-Resistant Prostate Cancer and Other Tumors
NCT06072612	Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
NCT05856773	Conventionally Fractionated vs. Hypofractionated Comprehensive Nodal Irradiation for Breast Cancer Using Pencil Beam Scanning Proton Therapy
NCT07025369	Androgen Deprivation Therapy (Relugolix) for the Improvement of Diagnostic Imaging (PSMA PET/CT Scan) in Patients With High Risk or Very High Risk Prostate Cancer, The EnrichPSMA Trial
NCT06864754	WashU DIEP Flap Video and Patient Understanding Improvement
NCT06807359	Photodynamic Therapy of Primary Localized Prostate Cancer With the SpectraCure P18 System
NCT07218809	AZD5335 vs. Mirvetuximab Soravtansine in FRα-high and AZD5335 vs. Chemotherapy in FRα-low Platinum-resistant Ovarian Cancer
NCT05376592	Assoc. of Genomic Polymorphisms With Cancer Cachexia in Subjects With Panc Adenocarcinoma
NCT04812912	Changes in Reproductive and Sexual Health in People With Early Onset Colorectal Cancer
NCT06721065	A Study of Language Interpretation Solutions for People With Breast Cancer
NCT05218044	Cryoablation as a Minimally Invasive Alternative to Surgery for Managing Ductal Carcinoma In Situ
NCT07543757	Prostate Cancer Risk Identification in a Multi-Ethnic Cohort: a Prospective US-based Multi-center Validation Study of Proclarix
NCT06774963	A Phase 1 Study of LNCB74 in Advanced Solid Tumors
NCT02926690	Safety Study of MELK Inhibitor to Treat Patients With Advanced Breast Cancer and Triple Negative Breast Cancer
NCT04844528	Effects of Nicotinamide in Patients With Chronic Lymphocytic Leukemia With History of Non-melanoma Skin Cancers
NCT06294574	Improved Successful Retrieval Rate of HydroMARK Plus Breast Biopsy Site Marker in Comparison to HydroMARK as Well as Improved Surgeon Satisfaction
NCT04144023	A Vaccine (H2NVAC) Before Surgery for the Treatment of HER2-Expressing Ductal Carcinoma In Situ
NCT04729114	A Safety and Dose-finding Study of PRL-02 Depot in Men With Advanced Prostate Cancer
NCT03936478	Real-Time MRI-Guided 3-Fraction Accelerated Partial Breast Irradiation in Early Breast Cancer
NCT06581406	A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma
NCT07224789	Liquid Biopsy for Early Detection of Colorectal Cancer Using Circular RNA
NCT05826743	Safety and Effectiveness Evaluation of the COLO-BT as an Alternative Treatment to the Ileostomy
NCT07229443	CoGENES Randomized Controlled Trial (RCT)
NCT07218718	Oral Cryotherapy to Decrease Taste Changes in Prostate Cancer Patients Receiving Taxane Chemotherapy
NCT05497024	Older Men's Decision Making About Active Surveillance for Prostate Cancer - Aim 3: Decision Aid Cognitive and Usability Testing
NCT06885203	Social and Environmental Determinants of Breast Cancer Survivorship: the Black Breast Cancer Survivor's Intervention (BBCSI)
NCT05304962	FIH Study of RGT-419B Alone and With Endocrine Therapy in HR-Positive, HER2-Negative Advanced/Metastatic Breast Cancer
NCT05899361	A Novel Imaging Protocol in Use to Identify Lymph Nodes and Organs of Interest
NCT07080242	Evaluating BL-M14D1 in Subjects With Locally Advanced or Metastatic Small Cell Lung Cancer and Neuroendocrine Tumors
NCT04636710	Refining Local-Regional Therapy for IBC
NCT04337580	Fatty Acid Synthase Inhibition in Castration Refractory Prostate Cancer
NCT06728579	Enhanced Pain Coping in Cancer (EPIC): A Study of Managing Treatment-Related Joint Pain in Breast Cancer Survivors
NCT05483283	Empowering Vulnerable and Resilient Latinas to Obtain Breast Cancer Care
NCT07503808	A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types
NCT05512208	A Phase 2 Study of Avutometinib (VS-6766) Plus Defactinib
NCT05411718	A Phase IIa Randomized, Double-Blinded Clinical Trial of Naproxen or Aspirin for Cancer Immune Interception in Lynch Syndrome
NCT06534918	Precise Oncology Interventions in Nutrition and Training (OnPoint)
NCT05183126	Pharmacokinetic Study of Skeletal Muscle Area-based Paclitaxel Infusion in Patients With Cancer
NCT06957535	Community-led Navigation to Address Disparities in Mammography Among Native American Women
NCT00912717	Pancreatic Adenocarcinoma Gene Environment Risk Study
NCT01441089	Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
NCT06434064	Tamoxifen and Pegylated Liposomal Doxorubicin for the Treatment of Patients With Metastatic or Inoperable, Locally Advanced Triple Negative Breast Cancer
NCT04858009	Hyperthermic Intraperitoneal Chemotherapy for the Treatment of Pancreatic Cancer and Peritoneal Metastasis
NCT06439693	The SAPPHO Study: Sequential Therapy With Curative Intent in de Novo HER2+ Metastatic Breast Cancer
NCT06545604	Comprehensive Yoga Therapy Based Lifestyle Prehabilitation Program for Women With Ovarian Cancer
NCT06391099	Ketogenic Dietary Intervention to Improve Response to Immunotherapy in Patients With Metastatic Melanoma and Metastatic Kidney Cancer
NCT04698564	Utility of Hyperpolarized 13C-pyruvate Metabolic Magnetic Resonance Imaging
NCT05056844	Contrast Enhanced Spectral Mammography for the Evaluation of Pathologic Nipple Discharge
NCT02674100	American Hepato-Pancreato-Biliary Association (AHPBA) Pancreatic Irreversible Electroporation (IRE) Registry
NCT06682793	A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression
NCT03568630	Blood Markers of Early Pancreas Cancer
NCT03804944	Converting HR+ Breast Cancer Into an Individualized Vaccine
NCT02333604	Cancer Experience Registry (CER) for Cancer Patients and Caregivers
NCT07574671	Impact of Ketogenic Diet on Tumor Microenvironment in Patients With Breast Cancer
NCT00923221	Collection of Blood From Patients With Prostate Cancer
NCT05985655	Study to Assess GTAEXS617 in Participants With Advanced Solid Tumors
NCT04887935	Neoadjuvant SGLT2 Inhibition in Localized Prostate Cancer
NCT05868668	Efficacy of Low-intensity Shockwave vs Radial Wave for Treatment of Erectile Dysfunction and Pelvic Pain
NCT05074290	Pharmacokinetics and Safety of Epidiferphane and Taxanes in Breast Cancer Patients
NCT02290834	Chemotherapy-induced Cognitive and Brain Changes in Older Adults With Breast Cancer
NCT06998940	Studying Chemotherapy With or Without Panitumumab for Unresectable, Locally Advanced, or Metastatic Pancreatic Cancer Without KRAS Mutations
NCT07049276	The Multicentre Selective Lymphadenectomy Trial - 3
NCT03646617	Ipilumumab and Nivolumab With or Without Hypofractionated Radiotherapy in Patients With Metastatic Melanoma
NCT06412510	Prehabilitation for EOC, Fallopian Tube, Primary Peritoneal Carcinoma and Pancreatic Cancer w/ NACT
NCT06730347	A Study of Lorigerlimab in Participants With Advanced Solid Tumors
NCT06270706	A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
NCT05366699	LYMPHA Procedure for the Prevention of Lymphedema After Axillary Lymphadenectomy
NCT05508906	Phase 1b Study of OP-1250 (Palazestrant) in Combination With Ribociclib, Alpelisib, Everolimus, or Atirmociclib in ER+, HER2- Breast Cancer
NCT05637216	Losartan to Reduce Radiation Induced Fibrosis in Breast Cancer Patients
NCT05716516	STUDY02001740;22SCH740: Estradiol For ER+ Advanced Breast Cancer (ESTHER)
NCT04115306	Phase 1/1b/2 Study of Oral PMD-026 in Patients With Metastatic Breast Cancer
NCT05935384	SIBYL: obServation of Therapy Response With lIquid BiopsY evaLuation
NCT06896474	SDM POSSIBLE: A Breast Cancer Treatment Decision Aid for Women 70+ With Low-Risk Stage I Breast Cancers
NCT04986423	ZEN003694 and Enzalutamide Versus Enzalutamide Monotherapy in Metastatic Castration-Resistant Prostate Cancer
NCT05223803	TERPS Trial for de Novo Oligometastic Prostate Cancer
NCT04150042	SHARON: A Clinical Trial for Metastatic Cancer Using Chemotherapy and Patients' Own Stem Cells
NCT04711824	Study of Stereotactic Radiosurgery With Olaparib Followed by Durvalumab and Physician's Choice Systemic Therapy in Subjects With Breast Cancer Brain Metastases
NCT07055854	Virtual Mindful After Cancer (MAC) Intervention to Promote Sexual Health for Breast and Gynecologic Cancer Survivors
NCT07054346	Comparison of 177Lu-PSMA-617 and 225Ac-PSMA-617
NCT03934905	Protective Effects of the Nutritional Supplement Sulforaphane on Doxorubicin-Associated Cardiac Dysfunction
NCT06295159	Neoadjuvant and Adjuvant Anti-PD1 or Combinations for Locoregionally Advanced Melanoma
NCT06444269	Precision Medicine in Action: Phase II Trial of Response Adaptive Ablative Pre-operative SPBI (RAPS) and Non-operative Sentinel Lymph Node Biopsy in Patients With Early-stage ER+ Breast Cancer: RAPS Trial
NCT06512350	Identifying Patterns in the Breath of Individuals With Breast Cancer
NCT07193862	Pilot Study of an Implantable Microdevice for In Situ Evaluation of Drug Response in Patients With Colorectal Liver Metastasis
NCT04824027	Breast Elasticity Imaging During Neoadjuvant Chemotherapy
NCT06651580	Biospecimen Collection to Identify Gene Mutations for High Risk Pancreatic Cancer in Pediatric Patients, INSPPIRE 2 Study
NCT04167969	The Use of Nanoparticles to Guide the Surgical Treatment of Prostate Cancer
NCT05660083	Alpelisib/iNOS Inhibitor/Nab-paclitaxel in Patients With HER2 Negative Metaplastic Breast Cancer (MpBC)
NCT04562129	IL2 With Ipilimumab Followed by Nivolumab in Stage 3 or 4 Melanoma Patients
NCT06792695	A Study of Novel Study Interventions and Combinations in Participants With Colorectal Cancer
NCT04997096	Exercise as a Preventive Agent to Combat Immobility in Patients With Ovarian or Endometrial Cancers Receiving Chemotherapy
NCT06096688	Discovering New Targets for Colorectal and Endometrial Cancer Risk Reduction
NCT05882253	Prostate Cancer IMAGing IN Early Detection (IMAGINED Trial)
NCT04572451	Safety of SBRT With Anti-PD1 and Anti-IL-8 for the Treatment of Multiple Metastases in Advanced Solid Tumors and Melanoma
NCT06487507	Metabolic Impact and Compliance of Controlled, Varying, Mediterranean Diets in Pre-Surgical Prostate Cancer Populations (PROVISIONS)
NCT06039371	Supraphysiological Androgen to Enhance Treatment Activity in Metastatic Castration-Resistant Prostate Cancer, SPECTRA Study
NCT06457919	A Study of Tinengotinib (TT-00420) in Combination With Standard Treatments in People With Prostate Cancer
NCT06643767	Evaluation of the Bexa Breast Examination
NCT06058377	Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer
NCT06400563	MRg-NIRS Imaging System Breast Cancer Trial
NCT03723928	S1703 Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Receptor Positive Her2 Negative Metastatic Breast Cancer
NCT06568692	A Phase 2 Study of PCS6422 With Capecitabine in Patients With Advanced or Metastatic Breast Cancer
NCT07214883	UCF MammoChat: Image Repository
NCT06888102	A Platform Study of Epigenetic Therapy Before Prostatectomy in Men With Prostate Cancer
NCT06336902	Botensilimab Plus Balstilimab and Fasting Mimicking Diet Plus Vitamin C for Patients With KRAS-Mutant Metastatic Colorectal Cancer
NCT07224841	Development of a cfDNA 5mC/5hmC-based Biomarker Panel to Predict Targeted Therapy Efficacy in mCRC
NCT06538337	Hypofractionated External Beam Radiotherapy With Adaptive Planning for Endometrial and Cervical Cancers
NCT06966700	A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
NCT07125729	Minimal Residual Disease Testing for the Early Detection of Cancer Recurrence in Resectable Stage II-IV Colorectal Cancer Patients
NCT06520345	The Study of 177Lu-TLX591 Plus SOC Versus SOC Alone in Patients With mCRPC (ProstACT Global)
NCT05926102	The Prostate Cancer, Genetic Risk, and Equitable Screening Study (ProGRESS)
NCT06963905	Saci Nivo Rela for TNBC
NCT07030348	Early Diagnosis of Pancreatic Cancer Duodenal Fluid-Based Biomarker Exploratory Study
NCT06888921	A Clinical Trial to Evaluate the Safety and Efficacy of COM701 in Relapsed Platinum Sensitive Ovarian Cancer
NCT05245500	Phase 1 Study of MRTX1719 in Solid Tumors With MTAP Deletion
NCT06463028	Sapanisertib and Serabelisib (PIKTOR) With Paclitaxel and a Substudy With an Insulin-Suppressing Diet in Patients With Advanced/Recurrent Endometrial Cancer
NCT07432633	[18F]FPyQCP PET Imaging of Fibroblast Activation Protein in Selected Oncology Indications
NCT06855706	An Automated Personalized Physical Activity Intervention to Improve Immune Function and Clinical Outcomes in Stage II-IV Ovarian, Primary Peritoneal or Fallopian Tube Cancer and Newly Diagnosed Endometrial Cancer, Life on the Go 3 Study
NCT06070012	Tebentafusp in HLA-A*0201 Positive Previously Untreated Metastatic Uveal Melanoma
NCT02595957	Genomic Services Research Program
NCT05896839	Immunotherapy in Combination With Prednisone and Sirolimus for Kidney Transplant Recipients With Unresectable or Metastatic Skin Cancer
NCT05056857	Neutrophil Extracellular Traps Formation in Breast Cancer Patients Taking Tamoxifen
NCT04886531	Trial of Pre-operative Neratinib and Endocrine Therapy With Trastuzumab in ER-Positive, HER-2 Positive Breast Cancers
NCT06690775	CATALINA-2: A Clinical Study of TORL-1-23 in Platinum-resistant Ovarian Cancer.
NCT01035112	Magnetic Resonance Imaging of Breast Cancer
NCT05819892	Phase I Trial Testing the Safety and Tolerability of Chemoradiation Followed by Chemotherapy + Dostarlimab for Stage IIIC, Node Positive, Endometrial Cancer
NCT06182072	ProAgio in Pancreatic Ductal Adenocarcinoma (PDAC)
NCT03454035	Ulixertinib/Palbociclib in Patients With Advanced Pancreatic and Other Solid Tumors
NCT06559540	Ultra-Hypofractionated vs. Hypofractionated Radiation for Node-Positive Breast Cancer
NCT07336446	A Trial to Learn How Safe AZD9750 is and How Well it Works in People With Metastatic Prostate Cancer When Given With or Without Other Anticancer Drugs
NCT06574880	STereotActic Body Radiotherapy and 177Lutetium PSMA in Locally Advanced Prostate Cancer
NCT05624918	A Study of NovoTTF-200T(P) in Combination With Gemcitabine and Nab-Paclitaxel for Resectable Pancreatic Adenocarcinoma
NCT07554560	Nutrition Intervention for Pancreatic Cancer
NCT06075524	Evaluation of Anti-PD-1 Therapy by Monitoring T Cell Responses in Melanoma, Lung and Other Cancer Types
NCT05691010	A Study of Short-Course Radiation Therapy With Chemotherapy in People With Endometrial Cancer
NCT06429813	Remotely Monitored Exercise Interventions in Patients With mCSPC Undergoing ADT (Prostate 006)
NCT06817668	Evaluating Tolerability of ePUHRT With Brachytherapy Boost
NCT07214610	Integrating Biological, Clinical, and Behavioral Factors to Improve Breast Cancer Outcomes - Carolina Breast Cancer Study
NCT07115043	A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors
NCT04692818	3D Ultrasound Breast Imaging
NCT05997017	Trial of Nab-Sirolimus in Combination With Letrozole in Patients With Advanced or Recurrent Endometrioid Endometrial Cancer
NCT07559825	Early-Onset Colorectal Cancer Patients Too Young for Screening
NCT06136650	A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
NCT05049538	Determine the Utility of Liquid Biopsies and Tumor Molecular Profiling in Predicting Recurrence in Endometrial Cancers
NCT05111574	Using Nivolumab Alone or With Cabozantinib to Prevent Mucosal Melanoma Return After Surgery
NCT05295407	Performance of Inherited Risk Assessment for Predicting Prostate Cancer From Prostate Biopsy
NCT03833921	Evaluation of Response to Abiraterone/Prednisone by Race/Ethnicity and Other Factors in Metastatic Hormone Naive Prostate Cancer
NCT05254171	Study of Nab-Paclitaxel and Gemcitabine With or Without SBP-101 in Pancreatic Cancer
NCT07076121	A Study Comparing BMS-986504 in Combination With Nab-paclitaxel and Gemcitabine Versus Placebo in Combination With Nab-paclitaxel and Gemcitabine in Participants With Untreated Metastatic Pancreatic Ductal Adenocarcinoma With Homozygous MTAP Deletion (MountainTAP-30)
NCT06492616	A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
NCT04633252	A Phase I/II Study of PDS01ADC With Docetaxel and Abiraterone in Adults With Metastatic Castration Sensitive and PDS01ADC With Docetaxel in Castration Resistant Prostate Cancer
NCT06831838	A Randomized Controlled Trial (RCT) to Determine the Efficacy of a Multidisciplinary CBT Based Pain Management Program for the Treatment of Aromatase Inhibitor Associated Musculoskeletal Symptoms (AIMSS) in Breast Cancer Survivors
NCT07436078	Culturally Adapting an Intervention to Increase Genetic Testing in African American Cancer Survivors
NCT06169371	Abemaciclib Dose Escalation to Maintain Intensity (ADE-MI)
NCT04792684	Collection of Samples USOPTIVAL Study
NCT05592938	Partial Breast Re-irradiation Using Ultra Hypofractionation (PRESERVE)
NCT03011684	Fertility Preservation Using Tamoxifen and Letrozole in Estrogen Sensitive Tumors Trial
NCT06383026	Individuals on Hormone Therapy Breast Cancer Screening Pilot
NCT06039085	Microendoscopic EI Sensing for Real-time Intraoperative Surgical Margin Assessment
NCT03809585	Observational Study of Iris Tumors
NCT05868226	PRE-I-SPY Phase I/Ib Oncology Platform Program
NCT07182149	A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors
NCT04624555	The Utility and Feasibility of Mt-sDNA as a Surveillance Procedure in Colorectal Cancer Survivors
NCT06795009	Zanzalintinib in Combination With Paclitaxel in Recurrent High Grade Uterine Cancer
NCT01772771	Molecular Testing for the MD Anderson Cancer Center Personalized Cancer Therapy Program
NCT02997293	Impact of the Enhanced Recovery After Surgery System for Colorectal Surgery
NCT04862663	Capivasertib + CDK4/6i + Fulvestrant for Advanced/Metastatic HR+/HER2- Breast Cancer (CAPItello-292)
NCT04985032	Accelerated Partial Breast Irradiation (APBI) Using Stereotactic Body Radiation Therapy (SBRT)
NCT04990609	EUS-RFA PANCARDINAL-1 Trial
NCT05413421	Study of ORIC-944 in Patients With Metastatic Prostate Cancer
NCT03488693	Regional Radiotherapy in Biomarker Low-Risk Node Positive and T3N0 Breast Cancer
NCT07335354	A Study of a Decision Tool for People Considering Breast Reconstruction Surgery
NCT04511013	A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases
NCT06095089	A Study of JNJ-87189401 Combined With JNJ-78278343 for Advanced Prostate Cancer
NCT07053085	A Study of Surgery and Radiotherapy in People With Breast Cancer
NCT05325632	Study of HER2 Directed Dendritic Cell (DC1) Vaccine + Weekly Paclitaxel, Trastuzumab & Pertuzumab
NCT06504914	Preparing FIM-BCS - A Lifestyle Modification for African-American Breast Cancer Survivors
NCT06445738	Post-operative Radiotherapy Omission in Selected Patients With Early Breast Cancer Trial International VErsion (PROSPECTIVE)
NCT06731894	Phytocannabinoids for Reducing Chronic Chemotherapy-Induced Peripheral Neuropathy in Breast and Colon Cancer Survivors
NCT04550494	Measuring the Effects of Talazoparib in Patients With Advanced Cancer and DNA Repair Variations
NCT07164456	Together Stronger: A Family-centered Lifestyle Intervention for Black Prostate Cancer Survivors and Their Caregivers
NCT06067269	Hormone Therapy (Apalutamide) and Image-guided Stereotactic Body Radiation Therapy for the Treatment of Patients With Prostate Cancer, HEATWAVE Trial
NCT07126158	Stereotactic Body Radiotherapy Plus FAK and RAF/MEK Inhibition in Advanced Pancreatic Adenocarcinoma
NCT07090148	Trial of pTVG-HP+Nivo+Targeted Ablation of Resistant Lesions in Non-Castrate RecurrentOMPC
NCT07397338	Study of RAS(ON) Inhibitors in Combination With Ivonescimab in Patients With Solid Tumors
NCT06782555	A Study of Evofosfamide in Combination with Zalifrelimab and Balstilimab
NCT06948448	A Study to Evaluate the Safety and Efficacy of Two Dose Levels of ONO-4578 With Opdivo®, in Combination With mFOLFOX6 and Bevacizumab Versus Standard of Care in Participants With Non-MSI-H/dMMR, PD-L1 Positive Advanced Colorectal Cancer
NCT07379138	Studying Quality of Life Inclusive of Mental Health and Cognitive Behavioral Therapy for Cancer Distress for the Improvement of Quality of Life in Stage III-IV Melanoma Patients
NCT06798558	Neoadjuvant Lu-177-PSMA-617 in Patients With High Risk Localized Prostate Cancer Undergoing Radical Prostatectomy
NCT07207564	Integrating Molecular Pathology, Radiology, and Genetics to Improve Breast Cancer Risk
NCT06305299	Autologous CAR-T Cells Targeting B7H3 in Ovarian Cancer iC9-CAR.B7-H3 T Cells
NCT07016399	Neoadjuvant Darolutamide Alone or in Combination With Standard Therapy for Stage II-IIIA, AR+, TNBC
NCT06710132	Study of Anti-CEACAM5 ADC M9140 in Participants With Advanced Solid Tumors (PROCEADE PanTumor)
NCT06999798	An Optimized Ultrasound Twinkling Marker for the Imaging of Lymph Nodes in Patients With Clinically Node-Positive Breast Cancer, The UTMOST2 Trial
NCT04724499	Improving Cognitive Function Through High-intensity Interval Training in Breast Cancer Patients Undergoing Chemotherapy
NCT06428721	The Preventive Role of Fractionated Laser Resurfacing Against Actinic Neoplasia in an At-Risk Geriatric Population
NCT05939414	An Open-label Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan Versus Observation in PSMA Positive OMPC.
NCT07192614	A Study to Learn How Safe AZD6621 is, How Well it Works, and How it Moves Throughout the Body Over Time, in Adult Male Participants With Metastatic Prostate Cancer
NCT06066138	A Study of Therapeutic Drug Monitoring-Based Atezolizumab Dosing
NCT05766748	Study of Effect of Azeliragon in Patients Refractory to Prior Treatment of Metastatic Pancreatic Cancer
NCT06347705	A Study of 2141-V11 in Combination With Standard Treatments in People With Prostate Cancer
NCT05611931	Selinexor in Maintenance Therapy After Systemic Therapy for Participants With p53 Wild-Type, Advanced or Recurrent Endometrial Carcinoma
NCT05727904	Study to Investigate Lifileucel Regimen Plus Pembrolizumab Compared With Pembrolizumab Alone in Participants With Untreated Advanced Melanoma.
NCT06890338	A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.
NCT04263025	AMNIOX CORD Study - Radical Prostatectomy With and Without Cryopreserved Umbilical Cord Allograft
NCT06528990	Telehealth Intervention for Ostomy Self-Management
NCT04005690	Targeted Pathway Inhibition in Patients With Pancreatic Cancer
NCT05155046	18F-DCFPyL Imaging as a Method to Assess Treatment Response to Stereotactic Body Radiation Therapy
NCT06492070	Cryocompression With or Without Cilostazol for the Prevention of Paclitaxel-induced Neuropathy in Patients With Gynecological Cancers
NCT07264790	Assessment of Topical Minoxidil on Intraoperative Flap Perfusion and Cutaneous Flap Viability in Breast Recon
NCT05593497	A Single-Arm Phase II Study of Neoadjuvant Intensified Androgen Deprivation (Leuprolide and Abiraterone Acetate) in Combination With AKT Inhibition (Capivasertib) for High-Risk Localized Prostate Cancer With PTEN Loss
NCT06200259	Reduction of Gastrointestinal Toxicity in Prostate Cancer by Proton Spot Placement
NCT06121180	Study of Cemiplimab Plus Ziv-Aflibercept for Subjects With Metastatic Uveal Melanoma
NCT05518903	Investigational Scan (68Ga-FAPI-46 PET/CT) for Imaging of Cancer-Associated Fibroblasts for Localized Pancreatic Ductal Adenocarcinoma
NCT05832086	Intermittent Fasting Using a Fasting-Mimicking Diet to Improve Prostate Cancer Control and Metabolic Outcomes
NCT05804318	Daily Adaptive Radiation Therapy Using an Individualized Approach for Prostate Cancer
NCT06620627	Prospective Collection of Samples to Enable the Development of Natera Screening Assay for Early Cancer Detection
NCT05176483	Study of Zanzalintinib in Combination With Immuno-Oncology Agents in Participants With Solid Tumors
NCT04808427	Pilot Study to Investigate Magnetic Resonance (MR) Image Guided Focal Therapy in Prostate Cancer
NCT06284590	Study of the Efficacy of Intratumoral L19IL2 or L19TNF or L19IL2/L19TNF, in Combination with Pembrolizumab, in Unresectable Melanoma Patients
NCT07094113	AMG 410 Alone and in Combination With Other Agents in Participants With KRAS Altered Advanced or Metastatic Solid Tumors
NCT05946824	This Study is Evaluating a New Radiation Treatment Technique for Patients Who Have Had Prostate Cancer, Undergone Surgery for Cancer, and Then Have Evidence That Their Prostate Cancer Has Returned.
NCT06629779	A Study to Learn How PF-06821497 (Mevrometostat) Works in Men With Metastatic Castration-resistant Prostate Cancer.
NCT04913064	Effects of White Button Mushroom on Inflammation in Obese Postmenopausal Women at High Risk of Breast Cancer
NCT06930755	Study of NMS-03305293 in Adult Patients With Relapsed Ovarian Cancer
NCT06385925	A Study of TSN1611 Treating Patients With Advanced Solid Tumors Harboring KRAS G12D Mutation
NCT04172532	Testing the Addition of a New Anti-cancer Drug, M3814 (Peposertib), to the Usual Radiotherapy in Patients With Locally Advanced Pancreatic Cancer
NCT05998135	Repurposing Atovaquone for the Treatment of Platinum-Resistant Ovarian Cancer
NCT07443943	A Dietary Supplement (Resistant Potato Starch) for Reducing Musculoskeletal Symptoms in Individuals Planning to Receive Aromatase Inhibitor Therapy, AIMSS-RPS Trial
NCT06555133	Y-90, Capecitabine, and Atezolizumab for Oligometastatic CRC
NCT06148038	CBD for Breast Cancer Primary Tumors
NCT02253251	Clinical Validation of the Role of microRNA Binding Site Mutations in Cancer Risk, Prevention and Treatment
NCT06813053	A Novel Patient Decision Aid for Surgical Treatment Options in Early-Stage Breast Cancer
NCT02328677	ColoCare Study - Colorectal Cancer Cohort
NCT06760819	A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
NCT06496256	Barrigel® PPRT (Post-Prostatectomy Radiation Therapy) Trial
NCT03880422	Nutrition and Exercise Interventions for Androgen Deprivation Therapy-Induced Obese Frailty in Elderly and Non-Elderly Survivors of Advanced Prostate Cancer
NCT06130995	Relugolix + Enzalutamide Study in High-Risk Prostate Cancer
NCT04606030	LymphBridge: Surgical Evaluation for Breast Cancer-Associated Lymphedema (BioBridge)
NCT06613100	Evaluation of Neoadjuvant Xaluritamig in Localized Prostate Cancer
NCT07111507	A Study of Tarlatamab for People With Prostate Cancer
NCT06103864	A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer
NCT06599619	Effects of Anti-PD1 Adjuvant Checkpoint Blockade Immunotherapy on Atypical/Dysplastic Nevi
NCT03606967	Testing the Addition of an Individualized Vaccine to Durvalumab and Tremelimumab and Chemotherapy in Patients With Metastatic Triple Negative Breast Cancer
NCT04230109	Sacituzumab Govitecan In TNBC
NCT03384238	Panitumumab-IRDye800 in Patients With Pancreatic Cancer Undergoing Surgery
NCT06908928	A Dose Randomization Study of Bulumtatug Fuvedotin in TNBC Patients Previously Treated With ADCs
NCT05542407	ONC201 and Atezolizumab in Obesity-Driven Endometrial Cancer
NCT03643861	RAD 1802: Pilot Trial of Five Fraction Stereotactic Body Radiotherapy for Early Stage Breast Cancer Patients Eligible for Post-Operative Accelerated Partial Breast Irradiation (APBI)
NCT05245812	Safety and Feasibility of Robotic SP Nipple Sparing Mastectomy
NCT07288112	DOC1021 Dendritic Cell Immunotherapy for Refractory Melanoma
NCT03805919	Men at High Genetic Risk for Prostate Cancer
NCT06303505	FiH Study to Investigate Safety, PK and Efficacy of the NaPi2b ADC TUB-040 in Patients With PROC or r/r Adenocarcinoma NSCLC
NCT03408353	Mammography, Early Detection Biomarkers, Risk Assessment, and Imaging Technologies, MERIT Study
NCT05219695	Medical Imaging and Thermal Treatment for Breast Tumors Using Harmonic Motion Imaging (HMI)
NCT06524895	Reiki Breast Surgery QOL Project for Women Undergoing Breast Surgery
NCT03396341	Responses to Genetic Risk Modifier Testing Among Women With Pathogenic Variants in Breast Cancer Predisposition Genes
NCT01521741	Prospective Screening for Breast Cancer-related Lymphedema
NCT06710756	Lead-212 PSV359 Therapy for Patients With Solid Tumors
NCT06073431	LOTUS-CC: An Observational Research Study to Uncover Subtypes of Cancer Cachexia
NCT06654037	Testing the Addition of an Anti-Cancer Drug, Abemaciclib, to the Usual Chemotherapy Treatment (5-Fluorouracil) for Metastatic, Refractory Colorectal Cancer
NCT04722341	Time-Restricted Eating and Cancer: Clinical Outcomes, Mechanisms, and Moderators
NCT05607095	A Study of LN-144 or LN-145 in People With Advanced Uveal Melanoma, Undifferentiated Pleomorphic Sarcoma, or Dedifferentiated Liposarcoma
NCT07311993	Phase 1 Study of CLR 125 in Triple Negative Breast Cancer
NCT03054584	Genetic Basis of Melanocytic Nevi
NCT04489238	Collection of Information to Better Understand Young Onset Colorectal Cancer
NCT07049055	A Clinical Trial to Evaluate EDV Nanocell Therapy With Gemcitabine and Nab-paclitaxel in Pancreatic Cancer
NCT06218914	Phase 1 Study to Investigate TCRTs KRAS Mutation in Unresectable, Advanced, and/or Metastatic Solid Tumors
NCT07259304	Social Health, Activity Behaviors, and Quality of Life Among Young Adult Cancer Survivors
NCT06531499	A Study of Radiation Dosimetry, Safety, and Tolerability of Extended Lutetium (177Lu) Vipivotide Tetraxetan Treatment in Chemo-naïve Adults With Metastatic Castration-resistant Prostate Cancer: RADIOpharmaceutical DOSimetry Evaluation (RADIODOSE) Study
NCT07023887	Prospective Study of EXErcise Regimens After Treatment for Breast Cancer for Hypertrophy and Conditioning
NCT04333706	A Dose Finding Phase 1 of Sarilumab Plus Capecitabine in HER2/Neu-Negative Metastatic Breast Cancer and a Single-arm, Historically-controlled Phase 2 Study of Sarilumab Plus Capecitabine in Stage I-III Triple Negative Breast Cancer With High-Risk Residual Disease (EMPOWER)
NCT07071038	Evaluating the Use of a Medication 'Switch' vs Guideline-directed Interventions for Relieving Side Effects of Aromatase Inhibitors Among Breast Cancer Patients
NCT06998407	ORION-1: Study of AVZO-023 as a Single Agent and in Combination With AVZO-021, and/or Endocrine Therapy in Advanced Solid Tumors
NCT04030507	Screening Magnetic Resonance Imaging of the Brain in Patients With Breast Cancer
NCT04893109	ATEMPT 2.0: Adjuvant T-DM1 vs TH
NCT07393906	Colorectal Cancer Prevention Research Study: Eat Right, Screen Right
NCT05438511	A Formative Evaluation For Improving Breast Cancer Hormone Receptor Testing in Tanzania
NCT03412877	Administration of Autologous T-Cells Genetically Engineered to Express T-Cell Receptors Reactive Against Neoantigens in People With Metastatic Cancer
NCT03422198	Short Course Vaginal Cuff Brachytherapy in Treating Participants With Stage I-II Endometrial Cancer
NCT02012699	Integrated Cancer Repository for Cancer Research
NCT04567771	Comparison of Proton or Intensity Modulated Radiation Therapy After Surgery for Endometrial or Cervical Cancer
NCT04904757	Contrast-enhanced Spectral Mammography (CESM) Breast Cancer Screening
NCT04513028	Beta Glucan's Effect on Pembrolizumab Immunologic Response in Stage III-IV Melanoma
NCT05837767	A Study of Radiation Therapy to Treat Solid Tumor Cancer That Has Spread to Soft Tissue
NCT06612281	Evaluation of Gixam's Performance in a FIT Negative Population
NCT06138067	Patient Navigation Program to Improve Clinical Trial Enrollment in Cancer Patients
NCT05144698	RAPA-201 Therapy of Solid Tumors
NCT07147231	Testing the Effectiveness of the Anti-cancer Drug Pidnarulex (CX-5461), in Combination With Another Anti-cancer Drug Cemiplimab (REGN2810), in Treating Refractory Microsatellite Stable Colorectal Cancer
NCT07249775	A First-in-Human Study of FID-022 in Solid Tumor Patients
NCT07064018	Trial of Single Protein Encapsulated Doxorubicin, SPEDOX-6 in Advanced Malignancies
NCT05758688	PROton Therapy for Post Surgical Treatment of GYNecologic Cancer
NCT00991094	Data Collection for the Assessment of Acute and Late Normal Tissue in Patients Treated With Proton Therapy
NCT07095517	Pathways, Risk Factors, and mOleculeS to Prevent Early-onset Colorectal Tumors

Search Results: (30 results)

Phase 1/1b Study of Oral Drug PMD-026 in People with Metastatic Breast Cancer and Metastatic Triple Negative Breast Cancer

Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to the Usual Radiation Treatment for Newly Diagnosed Early Stage High Intermediate Risk Endometrial Cancer

A Study of EDP1503 in Patients With Colorectal or Triple Negative Breast Cancer or Cancer That Came Back After Treatment with a Checkpoint Inhibitor

RESTORE: A virtual study comparing 2 digital apps to improve mental and physical well-being of patients with stage I – 3 cancer

Abiraterone/Prednisone, Olaparib, or Abiraterone/Prednisone + Olaparib in Patients With Metastatic Castration-Resistant Prostate Cancer With DNA Repair Defects

Mobile Mindfulness Meditation Intervention to Improve Neuropathy in Cancer Survivors

Niraparib + Ipilimumab or Nivolumab in Pancreatic Cancer that Has Not Progressed After Platinum Chemotherapy (Parpvax)

Parenting Adolescent-Aged Children While Managing a Parental Cancer Diagnosis – Share Your Story

Mobile Mindfulness Meditation Intervention to Improve the Well-Being of Cancer Survivors

Nous-209 Genetic Vaccine for the Treatment of Microsatellite -High (MSI-H) Colorectal, Gastric and Gastro-esophageal junction Tumors

A Study of Rucaparib Verses Physician's Choice of Therapy in Patients With Metastatic Castration-resistant Prostate Cancer and Homologous Recombination Gene Deficiency (TRITON3)

Prostate Cancer Genetic Risk, Experience, and Support Study (PROGRESS)

A Study of Combination Immunotherapies in Patients Who Have Previously Received Treatment with Immune Checkpoint Inhibitors (QUILT-3.055)

Safety and Efficacy of Olaparib Combined with Agents Targeting DNA Damage Repair Compared to Olaparib Alone

A Study of Nivolumab Combined With Ipilimumab and Nivolumab Alone in Patients With Advanced or Metastatic Solid Tumors of High Tumor Mutational Burden

A Study of Nivolumab in Selected Uterine Cancer Patients

GENetic Education Risk Assessment and TEsting Study (GENERATE)

A Study in Advanced Breast Cancer Patients with BRCA 1/2 Mutations Evaluating Olaparib alone or in Combination with Atezolizumab

Combination Chemotherapy With or Without Atezolizumab in Treating Patients With Stage III Colon Cancer and Deficient DNA Mismatch Repair

PHACT Study: Population Health and Cancer Testing

Pilot Study of Denosumab in BRCA1 or BRCA2 Mutation Carriers Scheduling Risk-Reducing Salpingo-Oophorectomy

A Study in Hereditary Breast and Ovarian Cancer Families to Provide Men With Up To Date Information About the Personal Importance of Genetic Testing (GEM)

A Phase 2 Study of Nivolumab in Combination with Either Rucaparib, Docetaxel, or Enzalutamide in Men with Castration-resistant Metastatic Prostate Cancer (CheckMate-9KD)

A Study in Ovarian Cancer Patients Evaluating Rucaparib and Nivolumab as Maintenance Treatment Following Response to Front-Line Platinum-Based Chemotherapy (ATHENA)

Decision Navigation for Advanced Prostate Cancer Treatment Options Using mHealth

Safety and Efficacy of Olaparib Alone Or in Combination with Medication Targeting DNA Damaging Repair for Metastatic Triple Negative Breast Cancer

Olive Oil for High Risk Breast Cancer Prevention

Auricular Point Acupressure to Self-Manage Aromatase Inhibitor Musculoskeletal Symptoms in Breast Cancer Survivors

A Study to Evaluate Rucaparib in Combination With Other Anticancer Agents in Patients With a Solid Tumor (SEASTAR)

Study of Safety and Effectiveness of Motiva® Breast Implants

Additional Results on Clinicaltrials.gov
1000 results

Sponsored By

Knowledge Can Save Lives

Search Results: (30 results)

Additional Results on Clinicaltrials.gov 1000 results

Sponsored By

Knowledge Can Save Lives

Additional Results on Clinicaltrials.gov
1000 results